{"study_id": 11380, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-glucoside (C3G) and Vitisin A could mitigate androgenetic alopecia (AGA) by inhibiting androgen receptors and preventing DHT-induced hair follicle damage.", "results_summary": "Both C3G and Vitisin A inhibited androgen receptors, reduced DHT-induced apoptosis in human dermal papilla cells, regulated growth factors, and improved hair follicle health in mice by preventing Wnt10b and \u03b2-catenin repression.", "population_specificity": "Human dermal papilla cells (in vitro) and mice (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:43.923636+00:00"}
{"study_id": 11381, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of cyanidin-3-O-\u03b2-glucoside (C3G) in mitigating obesity-related complications through in vitro and in vivo studies.", "results_summary": "C3G demonstrated multiple biological benefits, including anti-obesity, antioxidant, anti-inflammatory, and metabolic regulatory effects by modulating genes and signaling pathways related to glucose, fatty acid, and lipid metabolism. The review concluded that C3G consumption may protect against obesity-related issues by maintaining body weight and metabolic balance.", "population_specificity": "Not specified (in vitro and in vivo studies, likely animal and cellular models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:44.021794+00:00"}
{"study_id": 11385, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of covalent and non-covalent interactions between myofibrillar protein (MP) and cyanidin-3-O-glucoside (C3G) on protein structure, binding sites, and digestion properties.", "results_summary": "The study confirmed covalent bonding between C3G and amino acid side chains in MP, identifying 30 modification sites. C3G significantly reduced MP digestibility, with covalent conjugates showing lower digestibility than non-covalent ones, particularly during intestinal digestion due to inhibited trypsin targeting sites.", "population_specificity": "Not specified (in vitro study using myofibrillar protein and C3G).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:44.349950+00:00"}
{"study_id": 11379, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether Cyanidin, alone or combined with Trametinib, could improve pathology in muscular dystrophy by modulating the MAPK pathway and Nfix expression.", "results_summary": "Cyanidin combined with Trametinib reduced Nfix in myogenic cells but caused ectopic calcifications in dystrophic muscles. However, Cyanidin prevented Trametinib-induced calcifications in Diaphragm and Soleus, showing histological improvements.", "population_specificity": "Adult Sgca null mice (a model for muscular dystrophy)", "effective_dosage": "Not specified", "study_duration": "Chronic treatment (exact duration not specified)", "interactions": "Trametinib (MEK inhibitor)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:44.414625+00:00"}
{"study_id": 11383, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Cyanidin-3-O-glucoside (C3G) on amyloidogenic pathways, autophagy, tau phosphorylation, neuronal cell death, and synaptic plasticity in an Alzheimer's disease mouse model.", "results_summary": "C3G reduced amyloid-beta peptides, improved autophagy, mitigated tau phosphorylation, and enhanced synaptic function and plasticity in APPswe/PS1\u0394E9 mice. It also modulated key signaling pathways, demonstrating neuroprotective effects.", "population_specificity": "APPswe/PS1\u0394E9 transgenic mice (Alzheimer's disease model).", "effective_dosage": "30 mg/kg/day, orally administered.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:45.627573+00:00"}
{"study_id": 11390, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) and its metabolite protocatechuic acid (PCA) could mitigate BPA-induced male reproductive toxicity.", "results_summary": "C3G and PCA increased testosterone and luteinizing hormone levels, improved sperm quality, alleviated apoptosis and oxidative stress in Leydig cells, and competitively bound to estrogen receptors, reducing BPA's harmful effects.", "population_specificity": "Male rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:51.932812+00:00"}
{"study_id": 11388, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential therapeutic and protective effects of Cyanidin-3-O-glucoside (C3G) on inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD).", "results_summary": "C3G demonstrated antioxidative, anti-inflammatory, cytoprotective, and antimicrobial effects, inhibiting NF-\u03baB pathway activation and activating the Nrf2 pathway. It also modulated gut microbiota and reduced pro-inflammatory cytokines in UC and CD patients.", "population_specificity": "Patients with inflammatory bowel diseases (ulcerative colitis and Crohn's disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:51.992696+00:00"}
{"study_id": 11386, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effects of cyanidin, peonidin, and cyanidin-3-galactoside on tyrosinase activity and their potential as treatments for melanin-related diseases.", "results_summary": "Cyanidin showed the strongest inhibitory effect on tyrosinase, followed by peonidin and cyanidin-3-galactoside. The binding of these anthocyanins to tyrosinase induced conformational changes and fluorescence quenching, suggesting potential therapeutic applications.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:52.169502+00:00"}
{"study_id": 11389, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To investigate the role of cyanidin-3-O-glucoside (C3G) in renal ischemia/reperfusion injury and its potential mechanisms.", "results_summary": "C3G reduced renal dysfunction, tissue damage, apoptosis, and endoplasmic reticulum stress in mouse models, with the most pronounced effect at 200 mg/kg. It also inhibited oxidative stress and the JAK/STAT pathway, suggesting therapeutic potential for renal I/R injury.", "population_specificity": "Mouse models and in vitro cellular models.", "effective_dosage": "200 mg/kg (most effective dosage mentioned).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:52.338420+00:00"}
{"study_id": 11392, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the hemodynamic effects and potential cardiovascular benefits of Cyanidin 3-O-glucoside (C3G) in rats, focusing on blood flow, blood pressure, and angiogenesis.", "results_summary": "A single oral dose of C3G significantly increased blood flow and aortic Akt phosphorylation, while repeated administration for 14 days reduced mean blood pressure and increased angiogenesis markers in skeletal muscle.", "population_specificity": "Male rats (cremaster muscle arteriole and aortic tissue).", "effective_dosage": "Not specified (single and repeated oral doses).", "study_duration": "Acute (60 minutes) and repeated (14 days).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:53.898551+00:00"}
{"study_id": 11391, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to elucidate the mechanism by which cyanidin inhibits adipocyte formation in 3T3-L1 preadipocytes.", "results_summary": "Cyanidin inhibited adipogenesis by downregulating adipogenic marker genes (PPAR\u03b3, C/EBP\u03b1, adiponectin, and aP2) without affecting cell viability. It increased intracellular Ca2+ via the PLC-IP3 pathway, suggesting a mechanism for its anti-obesity effects.", "population_specificity": "3T3-L1 preadipocytes (in vitro cell line study)", "effective_dosage": "1-50 \u03bcM for adipogenesis inhibition; 30-100 \u03bcM for Ca2+ signaling", "study_duration": "4 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:53.931060+00:00"}
{"study_id": 11387, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the synergistic inhibitory effects of quercetin (QUR) and cyanidin-3O-sophroside (C3S) on ABCB1 (P-glycoprotein) activity and their potential to enhance chemotherapy efficacy in multidrug-resistant tumors.", "results_summary": "The study found that combining QUR and C3S resulted in stronger ATPase inhibition and reduced substrate transport by ABCB1, suggesting a synergistic inhibitory effect. Molecular docking and simulations supported simultaneous binding of QUR and C3S to ABCB1, with C3S occupying the central substrate binding site and QUR the \"access tunnel.\"", "population_specificity": "In vitro and in silico models (not specified for human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Synergistic interaction with quercetin (QUR); potential interaction with chemotherapy drugs via ABCB1 inhibition.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:54.660239+00:00"}
{"study_id": 11393, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cyanidin could prevent anxiety-like effects and neuroimmune dysregulation caused by withdrawal from the synthetic cathinone MDPV.", "results_summary": "Cyanidin prevented MDPV withdrawal-induced anxiety-like behavior and normalized elevated cytokine levels in the ventral tegmental area, as well as glutamate transporter mRNA levels in the amygdala. It showed no adverse effects on locomotor activity, aversion, or reward.", "population_specificity": "Rats undergoing MDPV withdrawal.", "effective_dosage": "0.5 mg/kg, intraperitoneally, daily.", "study_duration": "9 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:54.914581+00:00"}
{"study_id": 11394, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of casein/cyanidin-3-O-glucoside nanoparticles (Cs-C3G) on gut microbiota disorders and metabolic health in high-fat-diet-fed mice.", "results_summary": "Cs-C3G reduced fat accumulation and liver oxidative stress, restored gut microbiota diversity, lowered the Firmicutes-to-Bacteroidetes ratio, increased beneficial microorganisms, and decreased opportunistic pathogens.", "population_specificity": "C57BL/6 mice fed a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:33:59.979694+00:00"}
{"study_id": 11395, "supplement_id": 1063, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Cyanidin-3-O-glucoside (C3G) on human gastric cancer cells and its underlying molecular mechanisms.", "results_summary": "C3G demonstrated significant antiproliferative effects on gastric cancer cells, induced apoptosis, arrested the cell cycle in the G2/M phase, and inhibited cell migration by modulating ROS levels and signaling pathways like AKT, MAPK, STAT3, and NF-\u03baB.", "population_specificity": "Human gastric cancer cells (MKN-45) and normal cells (unspecified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:01.133428+00:00"}
{"study_id": 11397, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hepatoprotective ability of cyanidin (Cy) and investigate its mechanisms in mitigating acute liver injury induced by carbon tetrachloride (CCl4).", "results_summary": "Cyanidin significantly and dose-dependently ameliorated acute liver injury, reducing oxidative stress and inflammatory responses by enhancing antioxidant capacity and inhibiting NF-\u03baB signaling. High-dose Cy showed effects comparable to silymarin, a positive control.", "population_specificity": "Not specified (animal model implied by CCl4-induced liver injury).", "effective_dosage": "High-dose and unspecified lower doses (exact amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:01.718210+00:00"}
{"study_id": 11396, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the skin hydration effects of cyanidin-3,5-O-diglucoside (CDG) from rose petal extract and elucidate its molecular mechanism.", "results_summary": "CDG was identified as the most potent compound in rose petal extract for improving skin hydration by upregulating HAS2 expression through the GLK-MAP2K-MAPK signaling pathway. The study demonstrated significant hydration improvements in human skin and increased hyaluronic acid levels in keratinocytes and a 3D skin model.", "population_specificity": "Human participants (specific demographics not detailed) and in vitro models (keratinocytes, 3D human skin equivalent).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:01.784388+00:00"}
{"study_id": 11398, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) and verbascoside (Verb) could protect retinal endothelial cells from high glucose-induced damage.", "results_summary": "C3G and Verb restored cell viability and reduced ROS levels in high glucose conditions, with the combination showing superior protection. They also preserved blood-retinal-barrier integrity and counteracted the down-regulation of tight junction proteins.", "population_specificity": "Human Retinal Endothelial Cells (HREC) in vitro", "effective_dosage": "5-50 \u03bcM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:02.262589+00:00"}
{"study_id": 11400, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer potential of cyanidin, focusing on its mechanisms of action against various cancer types.", "results_summary": "Cyanidin demonstrated anticancer activity by inhibiting RAS and MAPK pathways, activating caspases-3 and P-38, inducing cell cycle arrest, and altering redox status. It also enhanced chemotherapeutic effects on resistant cancer cells.", "population_specificity": "Not specified (in vitro or in vivo studies implied but not detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:02.501936+00:00"}
{"study_id": 11399, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-tumor effect of cyanidin on glioma stem cells (GSCs) and its potential mechanism via the Wnt signaling pathway.", "results_summary": "Cyanidin significantly reduced cell viability in all GSC lines, regulated the Wnt signaling pathway, and altered protein levels of \u03b2-catenin, c-Myc, Twist1, and Snail1, suggesting an anti-tumor effect.", "population_specificity": "Seven glioma stem cell (GSC) lines (GBM2, GBM7, G166, G179, G144, GliNS2, and 293T cells).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:02.814438+00:00"}
{"study_id": 11401, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin chloride (Cycl) has antidepressant effects in an LPS-induced depression model and to explore its potential mechanisms, including anti-inflammatory and neuroprotective actions in the hippocampus.", "results_summary": "Cycl significantly reduced depressive-like behaviors in LPS-challenged mice, suppressed hippocampal inflammation (TNF-\u03b1, IL-6, microglial hyperactivity), and restored expression of neurotrophic factors (GFAP, BDNF) and glutamate transporters (GLAST, EAAT2). These effects were also confirmed in cultured BV2 and U251 cells.", "population_specificity": "LPS-challenged mice and cultured BV2 and U251 cells.", "effective_dosage": "20 or 40 mg/kg, administered intraperitoneally for 5 days.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:04.965690+00:00"}
{"study_id": 11408, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether converting condensed tannins in chokeberries into cyanidin could enhance antioxidant activity and improve gut microbiota function.", "results_summary": "The study found that the optimal conversion treatment increased cyanidin yield by 1.50-fold, significantly boosting total and cellular antioxidant activity. It also positively influenced gut microbiota diversity.", "population_specificity": "In vitro (simulated digestion and fermentation)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:10.060463+00:00"}
{"study_id": 11404, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the therapeutic effect of Chinese bayberry (containing Cyanidin-3-glucoside, C3G) on antibiotic-associated diarrhea (AAD) and elucidate its underlying mechanisms.", "results_summary": "Dried bayberry powder and C3G reduced diarrhea scores, improved gut microbiota diversity, decreased harmful bacteria, reduced inflammation, and restored intestinal tight junction proteins. C3G was identified as the likely primary active component.", "population_specificity": "BALB/c mice with lincomycin-induced AAD.", "effective_dosage": "C3G suspension (40 mg/kg).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:10.208354+00:00"}
{"study_id": 11403, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to study the absorption, transport, and anti-inflammatory effects of Cyanidin-3-glucoside (C3G) nanoliposomes in a Caco-2/RAW 264.7 co-culture model simulating intestinal inflammation.", "results_summary": "C3G nanoliposomes showed concentration-dependent uptake and transport, primarily via endocytosis, and significantly reduced pro-inflammatory cytokine expression (TNF-\u03b1, IL-1\u03b2, IL-6, IL-8) compared to free C3G, indicating stronger anti-inflammatory potential.", "population_specificity": "Caco-2/RAW 264.7 co-culture model (in vitro intestinal inflammation system).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:10.561976+00:00"}
{"study_id": 11407, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antifibrotic properties of Cyanidin-3-galactoside (C3G) in mitigating silica particle-induced pulmonary fibrosis in mice.", "results_summary": "C3G treatment significantly reduced pulmonary fibrosis and cell infiltration, inhibited TGF-\u03b2/mTOR signaling via the NRF2/HO-1 pathway, and ameliorated epithelial-mesenchymal transition (EMT) in mice. The highest dose (400 mg/kg) showed the most pronounced effects, restoring key markers to control levels.", "population_specificity": "Mice exposed to silica particles (SP).", "effective_dosage": "100, 200, and 400 mg/kg body weight.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:11.665882+00:00"}
{"study_id": 11405, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could mitigate the oxidative stress and lifespan reduction caused by polystyrene (PS) exposure in Caenorhabditis elegans, focusing on the role of the DAF-16 pathway.", "results_summary": "C3G treatment improved oxidative stress and extended lifespan in wild-type C. elegans by enhancing the DAF-16 pathway and its downstream antioxidant genes, particularly sod-3. These benefits were diminished in daf-16(-) mutants, indicating the pathway's critical role in C3G's effects.", "population_specificity": "Caenorhabditis elegans (wild-type and daf-16(-) mutant strains)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:12.005549+00:00"}
{"study_id": 11406, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate how thermal-induced interactions between \u03b2-conglycinin (7S) and cyanidin-3-O-glucoside (C3G) affect the bioaccessibility and antioxidant capacity of C3G.", "results_summary": "Thermal treatment increased the binding affinity of 7S-C3G complexes but decreased C3G bioaccessibility and showed an antagonistic effect on antioxidant capacity. Higher temperatures (65\u00b0C and 121\u00b0C) significantly reduced C3G bioaccessibility and amplified the antagonism between 7S and C3G.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "High ratio of 7S to C3G (1:100).", "study_duration": "Not specified.", "interactions": "Interaction with \u03b2-conglycinin (7S) noted, reducing bioaccessibility and antioxidant capacity.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:12.773907+00:00"}
{"study_id": 11409, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether cyanidin 3-glucoside (C3G) stimulates hepatocyte growth factor (HGF) production in normal human dermal fibroblasts (NHDFs) and the underlying mechanisms.", "results_summary": "C3G induced HGF production at mRNA and protein levels in NHDFs, activated \u03b22-adrenergic receptor (\u03b22AR) signaling, and increased intracellular cAMP levels, while cyanidin (aglycon of C3G) did not show these effects.", "population_specificity": "Normal human dermal fibroblasts (NHDFs) and HEK293 cells expressing \u03b22AR.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:14.018374+00:00"}
{"study_id": 11411, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of cyanidin-3-O-glucoside on Parkinson's disease (PD) in mice, focusing on its potential to modulate gut microbiota and metabolic pathways.", "results_summary": "Cyanidin-3-O-glucoside protected MPTP-induced PD mice, altered 67 metabolites linked to gut microbiota dysbiosis, and showed significant changes in 5 phyla and 22 genera. The study also identified correlations between gut microbiota and amino acid metabolism.", "population_specificity": "MPTP-induced Parkinson's disease mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:19.134567+00:00"}
{"study_id": 11402, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the molecular mechanism by which Cyanidin-3-O-glucoside (C3G) promotes bone formation and its potential therapeutic effects on osteoporosis.", "results_summary": "The study identified 34 upregulated and 17 downregulated genes in C3G-treated osteoblasts, with enrichment in lysosome and glycolipid biosynthesis pathways. Key genes (Atp6v0c, Cx3cl1, Ly6a) linked to osteoporosis were validated, suggesting C3G's potential in bone metabolism disorders.", "population_specificity": "MC3T3-E1 mouse osteoblasts", "effective_dosage": "100 \u03bcmol/L", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:19.562953+00:00"}
{"study_id": 11412, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective role of Cyanidin-3-O-glucoside (C3G) on palmitic acid-induced pancreatic beta cell dysfunction and decipher its molecular mechanisms.", "results_summary": "C3G dose-dependently improved beta cell secretory function and reduced apoptosis by downregulating the PERK ER stress pathway, particularly the pro-apoptotic marker CHOP, as validated by RNA sequencing and siRNA experiments.", "population_specificity": "Primary isolated mouse islets and INS-1E cells.", "effective_dosage": "12.5 \u00b5M, 25 \u00b5M, 50 \u00b5M.", "study_duration": "12, 24, 48 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:19.567087+00:00"}
{"study_id": 11410, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how heat treatment and interactions with \u03b2-lactoglobulin (\u03b2-Lg) affect the stability, antioxidant capacity, and bioaccessibility of Cyanidin-3-O-glucoside (C3G).", "results_summary": "The study found that \u03b2-Lg protected C3G from heat-induced degradation, increased its antioxidant capacity by 4-10%, and significantly enhanced its bioaccessibility (up to 354.62% at 121\u00b0C). Non-covalent interactions between C3G and \u03b2-Lg were stronger at high temperatures (85-121\u00b0C).", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with \u03b2-lactoglobulin noted, enhancing stability and bioaccessibility of C3G.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:20.393984+00:00"}
{"study_id": 11413, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-glucoside (C3G) could overcome temozolomide resistance in glioma cells and explore the role of miR-214-5p in this process.", "results_summary": "C3G upregulated miR-214-5p, enhanced temozolomide's cytotoxic effect, and downregulated \u03b2-catenin and MGMT in resistant glioma cells. Combining C3G or miR-214-5p agomir with temozolomide significantly inhibited tumor growth.", "population_specificity": "TMZ-resistant LN-18/TR glioma cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:20.596821+00:00"}
{"study_id": 11414, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of cyanidin on human nucleus pulposus cells (HNPC) metabolism and its mechanism, particularly its role in attenuating high hydrostatic pressure-induced degradation.", "results_summary": "Cyanidin reversed the negative effects of high hydrostatic pressure (30 atm) on HNPC viability, proteoglycan synthesis, and cell matrix levels by blocking the Wnt/\u03b2-catenin signaling pathway. The effects of cyanidin were further reversed by SKL2001, an activator of the same pathway.", "population_specificity": "Human nucleus pulposus cells (HNPC) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:21.506036+00:00"}
{"study_id": 11415, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the metabolic impact of Cyanidin-3-O-glucoside (C3G) on glucose metabolism and its underlying molecular mechanisms, particularly its anti-diabetic effects related to GLUT-1.", "results_summary": "C3G significantly reduced fasting blood glucose levels and increased glycogen synthesis in diabetic db/db mice, linked to upregulated GLUT-1 expression. In liver cells, C3G promoted glucose consumption via the Wnt/\u03b2-catenin-WISP1 pathway, an effect blocked by GLUT-1 inhibition.", "population_specificity": "Diabetic db/db mice and liver cell lines (HepG2, L02).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:22.115151+00:00"}
{"study_id": 11416, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine the neuroprotective effects of Cyanidin-3-O-glucoside (C3G) and its metabolites, focusing on their ability to reduce A\u03b2 aggregation, oxidative damage, and inflammation.", "results_summary": "C3G significantly suppressed A\u03b2 aggregation, enhanced antioxidant capacity, improved memory in C. elegans, and reduced inflammation and oxidative damage in BV2 microglia cells. Its metabolites (Cy and OP) showed similar efficacy, while PCA had limited effects.", "population_specificity": "Transgenic Caenorhabditis elegans (A\u03b2 model) and BV2 microglia cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:23.085994+00:00"}
{"study_id": 11418, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-glucoside (C3G) could improve impaired fertility in mice with ulcerative colitis by inhibiting inflammatory cytokines.", "results_summary": "C3G-treated mice showed improved body weight, colon length, sperm count, and reduced inflammation compared to the DSS-induced colitis group, suggesting C3G may protect fertility by suppressing inflammatory mediators.", "population_specificity": "Male mice with DSS-induced colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:27.522629+00:00"}
{"study_id": 11417, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of cyanidin-3-glucoside (C3G) and blueberry pectin (BP) complexes, particularly after high hydrostatic pressure (HHP) treatment, on mice with DSS-induced colitis.", "results_summary": "HHP-treated C3G-BP complexes significantly alleviated colitis symptoms in mice, including diarrhea, blood loss, and colon shortening. The mechanism involved reducing oxidative stress, modulating inflammatory factors, inhibiting the NF-\u03baB pathway, and improving gut microbiota composition.", "population_specificity": "Mice with dextran sodium sulfate (DSS)-induced colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:28.062352+00:00"}
{"study_id": 11421, "supplement_id": 1063, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore whether Cyanidin-3-O-glucoside (C3G) could alleviate polystyrene (PS)-induced toxicities and gut microbiome perturbations in C57BL/6 mice.", "results_summary": "C3G supplementation reduced tissue accumulation of PS, promoted fecal PS discharge, alleviated oxidative stress and inflammatory response, and modulated gut microbiome perturbations, including regulating functional bacteria linked to inflammation.", "population_specificity": "C57BL/6 mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:28.563304+00:00"}
{"study_id": 11419, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of high-pressure processing (HPP) on the binding capacity, stability, and antioxidant properties of cyanidin-3-glucoside (C3G) when complexed with rhamngalacturonan I (RG-I) pectin.", "results_summary": "HPP increased the binding rate between C3G and RG-I pectin by 32.8%, improved C3G stability (retention rates increased by 34.0% after heat treatment and 38.3% after simulated digestion), and maintained its antioxidant capacity.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "15 minutes (HPP treatment duration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:28.815482+00:00"}
{"study_id": 11420, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antimicrobial potential and mechanisms of an acylated anthocyanin (C3G-LA) to guide its application as a food preservative.", "results_summary": "C3G-LA showed strong antibacterial activity against Staphylococcus aureus (MIC = 0.3125 mg/mL) and modest activity against Escherichia coli (MIC = 5 mg/mL). It disrupted membrane integrity, reduced intracellular ATP and pH, and altered cellular morphology, indicating membrane dysfunction.", "population_specificity": "Bacterial cultures (Staphylococcus aureus and Escherichia coli).", "effective_dosage": "0.3125 mg/mL (S. aureus), 5 mg/mL (E. coli).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:29.637431+00:00"}
{"study_id": 11422, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers sought to determine whether cyanidin 3-O-\u03b2-galactoside from black chokeberry improves energy metabolism and cognitive function in aging mice.", "results_summary": "Cyanidin 3-O-\u03b2-galactoside alleviated brain glucose uptake decline, reduced neuronal damage in the hippocampus and cortex, decreased \u03b2-amyloid load, and improved performance in the Morris water maze test, suggesting neuroprotective effects via AKT-mediated energy metabolism regulation.", "population_specificity": "Aging mice", "effective_dosage": "25 and 50 mg/kg/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:29.842257+00:00"}
{"study_id": 11423, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the inhibitory mechanism of cyanidin-3-O-glucoside and (-/+)-catechin against tyrosinase using computational simulations and in vitro assessments.", "results_summary": "The study found that cyanidin-3-O-glucoside and (-/+)-catechin exhibited stable binding and oxidation by tyrosinase, with (-/+)-catechin showing substantial inhibition, suggesting potential for drug development against tyrosinase-associated diseases.", "population_specificity": "In vitro (mushroom and murine tyrosinases) and computational models.", "effective_dosage": "Not specified", "study_duration": "100 ns molecular dynamics simulations", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:30.934544+00:00"}
{"study_id": 11424, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the protective role and mechanism of Cyanidin-3-glucoside (C3G) against high glucose-induced damage in human nucleus pulposus cells (HNPCs).", "results_summary": "C3G improved cell viability, reduced apoptosis, decreased ROS generation, and mitigated extracellular matrix degradation in HNPCs under high glucose conditions, primarily through activation of the Nrf2/HO-1 signaling pathway.", "population_specificity": "Human nucleus pulposus cells (HNPCs) in vitro.", "effective_dosage": "12.5, 25, and 50 \u03bcM.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:31.944317+00:00"}
{"study_id": 11426, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could alleviate oxidative stress in pancreatic islets under hyperglycemic conditions and explore its mechanism of action.", "results_summary": "C3G effectively reduced oxidative stress in pancreatic islet cells by activating mitophagy via the PINK1-PARKIN pathway, and it improved oxidative stress markers and fasting blood glucose levels in diabetic db/db mice.", "population_specificity": "Pancreatic islet cell line NIT-1 and diabetic db/db mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:36.231475+00:00"}
{"study_id": 11428, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-Glucoside (C3G) could protect human islets from post-transplant stress by reducing oxidative damage, inflammation, and amyloid formation.", "results_summary": "C3G improved cell viability, reduced amyloid formation, decreased ROS, and lowered inflammatory markers (IL-1\u03b2, NLRP3) while increasing autophagic activity (LC3) in human islets exposed to stressors like amylin, A\u03b21-42, rapamycin, or H2O2. Some effects were statistically significant, while others showed trends without significance.", "population_specificity": "Human islets in vitro (laboratory setting).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:38.338211+00:00"}
{"study_id": 11425, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the cardioprotective effects of dietary anthocyanins, specifically cyanidin-3-glucoside (C3G), persist after cessation of intake and to investigate the underlying mechanisms.", "results_summary": "The study found that C3G-enriched diet reduced cardiac injury, oxidative stress, and mitochondrial damage after myocardial ischemia/reperfusion (I/R) injury, even a month after stopping the diet. The cardioprotection was linked to changes in gut microbiota rather than anti-inflammatory activity, as demonstrated by fecal microbiota transplantation transferring the protective effect.", "population_specificity": "Mice (including immune-deficient mice lacking mature B and T cells)", "effective_dosage": "Not specified", "study_duration": "1 month of C3G-enriched diet followed by 1 month of washout with standard diet", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:38.353406+00:00"}
{"study_id": 11430, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the gene expression profiles related to antioxidant, immune-related, and Alzheimer's disease pathways in mice treated with Cyanidin 3-O-glucoside (C3G) compared to controls.", "results_summary": "The study found that C3G upregulated six antioxidant genes and numerous immune-related genes in treated mice, suggesting potential antioxidant and immunomodulatory mechanisms. RT-PCR validation supported these findings, indicating C3G's possible therapeutic role in Alzheimer's disease.", "population_specificity": "Wild-type mice (C57BL/6J Jms) and an Alzheimer's mouse model (APPswe/PS1dE9 mice).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:39.170895+00:00"}
{"study_id": 11432, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the intestinal protective effects of Cyanidin-3-O-glucoside and explore its potential mechanisms in regulating the intestinal mucosal immune system.", "results_summary": "Cyanidin-3-O-glucoside showed protective effects against intestinal diseases by repairing the intestinal wall, inhibiting inflammation, and regulating gut microbiota, though animal and clinical studies were noted as inadequate.", "population_specificity": "Not specified (in vivo and in vitro studies referenced).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:39.718091+00:00"}
{"study_id": 11429, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop and evaluate a novel nanocarrier (nanofibersolosome) for the colonic delivery of cyanidin-3-O-glucoside (C3G) to enhance its stability and efficacy in treating or preventing inflammatory bowel diseases.", "results_summary": "The nanofibersolosome formulations demonstrated superior stability, encapsulation efficiency, and C3G retention compared to the reference lipid formulation, leading to higher C3G delivery to the colon. Additionally, the nanofibersolosome samples showed enhanced antioxidant activity and promoted short-chain fatty acid generation.", "population_specificity": "In vitro study (no human or animal subjects specified).", "effective_dosage": "Not specified (ratios of Fibersol\u00ae-2:lipoid S75 were 0.5-4).", "study_duration": "Not specified (storage and thermal treatments were evaluated at various temperatures and durations).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:39.969391+00:00"}
{"study_id": 11431, "supplement_id": 1063, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antioxidant and cytoprotective effects of Cyanidin-3-glucoside (C3Ghv) on pancreatic \u03b2-cells under oxidative stress induced by streptozotocin (STZ).", "results_summary": "C3Ghv pre-treatment improved cell viability, reduced oxidative stress markers (ROS, nitric oxide, MDA), decreased apoptotic protein ratios (Bax/Bcl-2), and enhanced cell cycle progression (M2 phase) in STZ-treated pancreatic \u03b2-cells.", "population_specificity": "Rat insulinoma cells (RINm5F).", "effective_dosage": "50 \u00b5g/mL (pre-treatment), 100 and 200 \u00b5g/mL (direct exposure).", "study_duration": "24 hours (pre-treatment and exposure).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:40.766677+00:00"}
{"study_id": 11433, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could enhance the efficacy of cisplatin (DDP) while reducing its toxic effects on cervical cancer HeLa cells.", "results_summary": "C3G-DDP combination significantly increased oxidative stress and apoptosis in HeLa cells by altering antioxidant enzyme activity, ROS levels, and Nrf2 signaling pathway components, suggesting improved cancer cell susceptibility to DDP.", "population_specificity": "Cervical cancer HeLa cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "Cisplatin (DDP).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:45.808779+00:00"}
{"study_id": 11434, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the protective mechanism of cyanidin-3-O-glucoside (C3G) and its metabolite protocatechuic acid (PCA) against IQ-induced cytotoxicity in HepG2 cells.", "results_summary": "C3G and PCA alleviated IQ-induced cytotoxicity and apoptosis in HepG2 cells, with C3G being more effective. Proteomics and molecular docking revealed that C3G targets XIAP, inhibiting apoptosis by hindering IQ binding to the BIR3 domain.", "population_specificity": "HepG2 cells (human liver cancer cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:46.933556+00:00"}
{"study_id": 11427, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of cyanidin on osteoblast proliferation, differentiation, and bone resorption, as well as its potential mechanisms of action in bone health.", "results_summary": "Cyanidin increased osteoblast proliferation and differentiation, reduced apoptosis, and decreased RANKL-induced osteoclast formation and bone resorption. It also modulated mitochondrial and epigenetic markers, suggesting potential anabolic effects on bone.", "population_specificity": "Cultured human hFOB 1.19 osteoblasts and transgenic medaka fish.", "effective_dosage": "1-4 \u03bcg/ml", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:47.269925+00:00"}
{"study_id": 11435, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to explore the effects of cyanidin-3-O-glucoside (Cy3G) on human amniotic epithelial cells (hAECs) and investigate its mechanisms, particularly in modulating adipocyte differentiation.", "results_summary": "The study found that Cy3G treatment led to significant transcriptomic changes in hAECs, with 109 genes upregulated and 232 downregulated. Upregulated genes were linked to \"response to muscle activity,\" while downregulated genes were associated with the cell cycle, suggesting Cy3G's potential role in modulating adipocyte differentiation.", "population_specificity": "Human amniotic epithelial cells (hAECs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:47.357990+00:00"}
{"study_id": 11436, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of Cyanidin-3-O-glucoside on cell cycle modulation in hepatic precancerous lesions induced by DEN/2-AAF in Wistar rats.", "results_summary": "Cyanidin administration mitigated hepatic precancerous lesions, reduced AFP levels, improved liver function, and modulated cell cycle-related RNA expressions, including decreasing MALAT1 and tubulin gamma 1 mRNA while increasing miR-125b. It also reduced GSTP foci and PCNA-positive nuclei.", "population_specificity": "Wistar rats with DEN/2-AAF-induced hepatic precancerous lesions.", "effective_dosage": "10, 15, and 20 mg/kg/d, administered for four consecutive days per week.", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:49.178458+00:00"}
{"study_id": 11437, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) enhances the antitumor effects of cisplatin (DDP) in cervical cancer cells and reduces chemotherapy-related adverse effects.", "results_summary": "The study found that C3G alone inhibited HeLa cell proliferation by 34.98%, and its combination with DDP enhanced inhibition to 63.38%. The combination also modulated key signaling pathways (PI3K/AKT/mTOR) and induced apoptosis more effectively than either treatment alone.", "population_specificity": "Cervical cancer cells (HeLa cell line)", "effective_dosage": "400 \u00b5g/ml C3G, 5 \u00b5g/ml DDP", "study_duration": "Not specified", "interactions": "Enhanced antitumor activity when combined with cisplatin (DDP)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:49.661120+00:00"}
{"study_id": 11438, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin could inhibit IL-17A/IL-17RA signaling, monocyte migration, and osteoclastogenesis in rheumatoid arthritis (RA).", "results_summary": "Cyanidin blocked IL-17A-induced monocyte migration, suppressed osteoclast formation, and downregulated key inflammatory markers via modulation of IL-17/p38 MAPK and IL-17A/STAT-3 signaling pathways. It also reduced RANKL expression and increased OPG in fibroblast-like synoviocytes.", "population_specificity": "Adjuvant-induced arthritic (AA) rats and their isolated monocytes/macrophages and fibroblast-like synoviocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:49.998228+00:00"}
{"study_id": 11439, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-\u03b2-glucoside (Cy-3-g) could attenuate pulmonary artery hypertension (PAH) and explore its potential mechanism of action.", "results_summary": "Cy-3-g significantly reduced pulmonary artery pressure, right ventricular hypertrophy, and vascular remodeling in PAH rats, while also suppressing pro-inflammatory factors, blocking oxidative stress, and inhibiting smooth muscle cell proliferation via the TGF-\u03b21/p38 MAPK/CREB pathway.", "population_specificity": "Rats with monocrotaline-induced PAH and human pulmonary arterial smooth muscle cells (SMCs) in vitro.", "effective_dosage": "200 or 400 mg per kg of body weight.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:50.611520+00:00"}
{"study_id": 11440, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects and underlying mechanisms of Cyanidin-3-O-glucoside (C3G) on osteoblast proliferation, differentiation, and mineralization, as well as its role in the ERK signaling pathway.", "results_summary": "C3G treatment enhanced osteoblast proliferation, mineralization, and the expression of osteocalcin (OC), while also increasing ERK phosphorylation, effects that were blocked by an ERK inhibitor. The findings suggest C3G promotes osteoblast activity via the ERK pathway, indicating potential for osteoporosis prevention and treatment.", "population_specificity": "Osteoblasts extracted from the hip joint of osteoporosis patients and MC3T3-E1 osteoblast cell line from mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:55.405639+00:00"}
{"study_id": 11443, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether cyanidin-3-O-glucoside in red rice could inhibit the AGE-RAGE signaling pathway through in silico analysis.", "results_summary": "Cyanidin-3-O-glucoside showed potential as an inhibitor of AGE-RAGE interactions, with binding energies suggesting it could interfere with AGEs binding to RAGE, particularly with imidazole, argypirimidine, and pyrralline. The study concluded that cyanidin-3-O-glucoside might regulate pro-inflammatory and oxidative damage pathways.", "population_specificity": "In silico (computer-based) analysis (no human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:55.995606+00:00"}
{"study_id": 11441, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of Cyanidin-3-glucoside (C3G) on myocardial ischemia-reperfusion injury and explore its underlying mechanisms.", "results_summary": "C3G reduced infarction area, mitigated pathological changes, inhibited oxidative stress, and suppressed ferroptosis-related protein expression in both in vivo and in vitro models. It also downregulated autophagy markers and promoted K11-linked ubiquitination of Beclin1, demonstrating potential cardioprotective effects.", "population_specificity": "Rats subjected to myocardial ischemia-reperfusion injury and H9c2 cells exposed to oxygen-glucose deprivation/reoxygenation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:56.065481+00:00"}
{"study_id": 11442, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the anti-allergic effects of cyanidin-3-O-glucoside (C3G) from black soybean hull extract (BSHE) on IgE-mediated type I allergic reactions.", "results_summary": "C3G inhibited degranulation in RBL-2H3 cells and suppressed passive cutaneous anaphylaxis (PCA) in mice, with intravenous administration showing stronger inhibition at lower doses compared to oral administration.", "population_specificity": "IgE-sensitized mice", "effective_dosage": "Oral: 200 \u03bcmol/kg C3G; Intravenous: 40 mg/kg C3G, 100 mg/kg BSHE (5.4% C3G)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:56.759831+00:00"}
{"study_id": 11444, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antitumor mechanism of cyanidin-3-O-glucoside (C3G) in vivo using a Drosophila model of malignant tumors.", "results_summary": "C3G inhibited tumor growth and invasion, extended survival, and reduced autophagy in tumor cells and their microenvironment by inhibiting the JNK pathway. Combining C3G with chloroquine (CQ) showed better efficacy than either treatment alone.", "population_specificity": "Drosophila (fruit flies) with malignant tumors induced by activated oncogene Raf and loss-of-function mutations in the tumor suppressor scribble.", "effective_dosage": "Dose-dependent, but specific amounts not provided.", "study_duration": "Not specified.", "interactions": "Enhanced efficacy when combined with chloroquine (CQ).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:58.182134+00:00"}
{"study_id": 11445, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the protective effects of native and preheated milk proteins and bioactive compounds on the stability of cyanidin-3-O-glucoside (C3G) under acidic and neutral conditions.", "results_summary": "Both native and preheated milk proteins significantly protected C3G, with WPI preheated at 85\u00b0C showing the best effect under neutral conditions. Gallic acid provided the most significant protective effect by further reducing C3G's thermal degradation rate by 44.6%.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Vitamin C accelerated C3G color loss, while EGCG and gallic acid improved thermal stability.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:58.720350+00:00"}
{"study_id": 11446, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how high hydrostatic pressure (HP) treatment affects the binding capacity, interaction, and antioxidant activity of cyanidin-3-glucoside (C3G) when combined with blueberry pectin (BP).", "results_summary": "HP treatment significantly improved the adsorption between C3G and BP, with the highest C3G concentration (382.1 \u00b1 13.2 \u03bcg/mg for BP) achieved at a 1:2 mass ratio, 400 MPa pressure, and 15-minute holding time. HP altered the characteristics of C3G-BP complexes, enhancing electrostatic interactions and protecting C3G's antioxidant activity.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "C3G-BP mass ratio of 1:2", "study_duration": "15-minute HP holding time", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:34:59.744594+00:00"}
{"study_id": 11447, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of cyanidin-3-O-glucoside (Cy3G) in inhibiting epithelial-to-mesenchymal transition (EMT), cell migration, and invasion in breast cancer cells, and to elucidate its underlying molecular mechanisms.", "results_summary": "Cy3G inhibited EMT and significantly suppressed migration and invasion of breast cancer cells by upregulating KLF4 expression, which was mediated through downregulation of FBXO32, the E3 ligase of KLF4. KLF4 knockdown nullified Cy3G's effects, confirming its central role in the observed outcomes.", "population_specificity": "MDA-MB-231 and MDA-MB-468 breast cancer cell lines.", "effective_dosage": "20 \u03bcM for 24 hours.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:00.160387+00:00"}
{"study_id": 11448, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of CY3D5G-rich extract on oxidative stress in D-galactose-induced accelerated aging in mice.", "results_summary": "CY3D5G-rich extract increased antioxidant enzyme activity, reduced oxidative stress markers, and modulated metabolic pathways linked to reduced ROS production in aged mice. Proteomic analysis identified significant changes in 243 proteins, suggesting CY3D5G's role in mitigating oxidative damage.", "population_specificity": "Male C57BL/6J mice with D-galactose-induced accelerated aging.", "effective_dosage": "700 \u03bcmol/kg body weight, orally administered.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:03.919948+00:00"}
{"study_id": 11450, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of cyanidin-3-O-glucoside (C3G) against lipotoxicity and inflammation induced by free fatty acids in intestinal epithelial cells.", "results_summary": "C3G pre-treatment reversed inflammation and oxidative stress caused by palmitic acid in Caco-2 cells, modulating NF-\u03baB and Nrf2 pathways. The results suggest C3G may be beneficial for intestinal inflammatory disorders.", "population_specificity": "In vitro study using Caco-2 human intestinal epithelial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:04.252492+00:00"}
{"study_id": 11449, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could alleviate high glucose-induced podocyte dysfunction and explore its potential mechanisms in diabetic nephropathy.", "results_summary": "C3G reversed high glucose-induced apoptosis, improved autophagy, and inhibited epithelial-mesenchymal transition (EMT) in podocytes by activating the SIRT1/AMPK pathway. These effects suggest C3G may protect against podocyte dysfunction in diabetic nephropathy.", "population_specificity": "MPC5 cells (a mouse podocyte cell line) under high glucose conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:04.845831+00:00"}
{"study_id": 11452, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to identify the potential anti-cancer effects of cyanidin 3-glucoside (RBC3G) from Thai rice bran on human prostate cancer (PC3) cells, focusing on its ability to inhibit epithelial-mesenchymal transition (EMT) and cancer cell motility.", "results_summary": "RBC3G inhibited EMT in PC3 cells by blocking cytoskeletal protein expression, reducing Smad/Snail signaling, and enhancing E-cadherin expression. It also suppressed matrix metalloproteinase-9 and nuclear factor-kappa B, slowing cancer cell migration and invasion.", "population_specificity": "Human prostate cancer (PC3) cells in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:08.102949+00:00"}
{"study_id": 11454, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the cytoprotective effects and molecular mechanisms of cyanidin-3-glucoside (C3G) against hydrogen peroxide-induced oxidative damage in HepG2 cells.", "results_summary": "C3G (2.5-10 \u03bcM) dose-dependently protected HepG2 cells from H2O2-induced oxidative damage by reducing ROS and MDA levels, enhancing antioxidant enzyme activities (SOD, GSH-Px, CAT), and modulating apoptosis-related protein expression. The protective effects were mediated via mitochondrial and external apoptotic pathways.", "population_specificity": "HepG2 cells (human liver cancer cell line)", "effective_dosage": "2.5-10 \u03bcM", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:09.115296+00:00"}
{"study_id": 11455, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether cyanidin-3-glucoside (Cy3G) exerts metabolic benefits via modulation of GLP-1, leptin, insulin, and FGF21 pathways in mice.", "results_summary": "Cy3G reduced body weight gain and improved glucose tolerance in high-fat diet mice, linked to increased hepatic Fgf21 expression and related gene activity, but did not affect plasma leptin, insulin, or GLP-1 levels. Antibiotics altered Cy3G's glucose tolerance effects, suggesting gut microbiota involvement.", "population_specificity": "Male C57BL-6J mice (6 weeks old)", "effective_dosage": "1.6 mg Cy3G/L in drinking water", "study_duration": "3 weeks (Experiment 1) and 20 weeks (Experiment 2)", "interactions": "Broad-spectrum antibiotics altered Cy3G's effects on glucose tolerance.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:11.133503+00:00"}
{"study_id": 11453, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Cyanidin-3-O-\u03b2-glucoside (Cy-3-G) could protect against alcohol-induced liver damage by suppressing inflammasome activation and NF-\u03baB acetylation.", "results_summary": "The study found that Cy-3-G attenuated liver damage caused by alcohol and excess energy intake by mediating NAD+ homeostasis, stimulating SirT1 activity, and suppressing NF-\u03baB acetylation and NLRP3 inflammasome activation, leading to reduced hepatic inflammation.", "population_specificity": "Hepatic cell lines (in vitro) and presumably animal models (implied by dietary provision, though not explicitly stated).", "effective_dosage": "Physiologically achievable dosage (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:13.152955+00:00"}
{"study_id": 11457, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the apoptotic effects of Cyanidin 3-O-Glucoside (C3G) on three osteosarcoma cell lines and explore its mechanisms of action.", "results_summary": "C3G induced apoptosis in osteosarcoma cell lines, with IC50 values of 110\u03bcg/ml for Saso-2 and G-292 cells and 140\u03bcg/ml for MG-63 cells. It upregulated PPAR\u03b3, P21, and Bax genes, with P21 protein overexpression confirmed by western blotting.", "population_specificity": "Three osteosarcoma cell lines (Saso-2, MG-63, G-292 clone A141B1).", "effective_dosage": "110\u03bcg/ml for Saso-2 and G-292 cells, 140\u03bcg/ml for MG-63 cells (24-hour exposure).", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:14.586498+00:00"}
{"study_id": 11458, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could protect human corneal epithelial cells (HCECs) from LPS-induced inflammation and apoptosis by modulating the let-7b-5p-mediated HMGA2/PI3K/Akt pathway.", "results_summary": "C3G increased cell viability, reduced apoptosis and inflammation in HCECs exposed to LPS, and upregulated let-7b-5p while inhibiting the HMGA2/PI3K/Akt pathway. The protective effects of C3G were blocked when let-7b-5p was inhibited, confirming its role in the mechanism.", "population_specificity": "Human corneal epithelial cells (HCECs) in vitro.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:15.019310+00:00"}
{"study_id": 11456, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cyanidin-3-O-glucoside (C3G) could alleviate non-alcoholic fatty liver disease (NAFLD) by promoting PINK1-mediated mitophagy.", "results_summary": "C3G administration reduced oxidative stress, NLRP3 inflammasome activation, and hepatic steatosis while improving glucose metabolism in NAFLD mice and human hepatocytes. These benefits were linked to enhanced PINK1/Parkin-mediated mitophagy, which was essential for C3G's effects.", "population_specificity": "Mice with high-fat diet-induced NAFLD and human AML-12/HepG2 hepatocytes.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:16.934968+00:00"}
{"study_id": 11451, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of cyanidin 3-O-glucoside (C3G) on T-cell function in spontaneously hypertensive rats (SHR) compared to hydrochlorothiazide (HCT).", "results_summary": "C3G increased proportions of certain T-cell subsets (CD62Llo and CD62L-) and boosted cytokine production (TNF\u03b1 and IFN\u03b3) in SHR, suggesting positive immune modulation, while HCT suppressed T-cell function.", "population_specificity": "Male spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats.", "effective_dosage": "10 mg kg-1 day-1", "study_duration": "15 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:17.613456+00:00"}
{"study_id": 11859, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to compare the impact of olanzapine, magnesium valproate, and lamotrigine as adjunctive treatments for anti-NMDAR encephalitis, focusing on neurotransmitter rebalance and clinical outcomes.", "results_summary": "Magnesium valproate and lamotrigine showed better outcomes than olanzapine, including lower PANSS scores, higher MoCA scores, and lower mRS scores, with improvements linked to decreased Glx/Cr ratios.", "population_specificity": "Patients diagnosed with anti-NMDAR encephalitis receiving standardized immunotherapy at Hunan Brain Hospital.", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:17.964728+00:00"}
{"study_id": 11459, "supplement_id": 1063, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the molecular mechanisms underlying the chemotherapeutic effects of cyanidin chloride (CyCl) in colorectal cancer cells, focusing on its impact on apoptosis, cellular proliferation, and signaling pathways (NF-\u03baB and Nrf2).", "results_summary": "CyCl treatment induced apoptosis, inhibited cellular proliferation and colony formation in colon cancer cells, suppressed NF-\u03baB signaling, and activated the Nrf2 pathway. Knockdown of Nrf2 inhibited CyCl's effects on NF-\u03baB signaling and apoptosis, indicating functional crosstalk between Nrf2 and NF-\u03baB.", "population_specificity": "Three colon cancer cell lines (HCT116, HT29, SW620).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:19.390197+00:00"}
{"study_id": 11860, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review how neuroinflammation mediates levodopa-induced dyskinesia (LID) through NMDA receptor regulation and assess potential therapeutic targets.", "results_summary": "The abstract suggests that neuroinflammation and NMDA receptor activation may play a role in LID development, but it does not present specific findings on D-Aspartic Acid's effects.", "population_specificity": "Patients with Parkinson's disease experiencing levodopa-induced dyskinesia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:19.460237+00:00"}
{"study_id": 11861, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a method to identify NMDA-2A ligands from natural products for potential use in Alzheimer's disease treatment.", "results_summary": "The study successfully developed a novel affinity stationary phase to screen NMDA-2A ligands, identifying crocetin as a compound that binds to NMDA-2A and increases its protein levels in a cellular AD model.", "population_specificity": "Cellular model of Alzheimer's disease", "effective_dosage": "Concentration-dependent (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:21.719462+00:00"}
{"study_id": 11864, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether antenatal memantine treatment could prevent heart injury in neonatal offspring exposed to intrauterine hypoxia.", "results_summary": "Intrauterine hypoxia caused mitochondrial dysfunction and structural abnormalities in offspring hearts, which were improved by antenatal memantine treatment. NMDAR activation by hypoxia led to mitochondrial damage, and blocking NMDARs attenuated these effects.", "population_specificity": "Pregnant rats and their neonatal offspring.", "effective_dosage": "Not specified", "study_duration": "Late pregnancy (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:25.142517+00:00"}
{"study_id": 11863, "supplement_id": 1064, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of D-Aspartic Acid (D-Asp) on pyroptosis in human gingival fibroblasts (HGFs) induced by HMGB1 and explore its potential protective mechanism.", "results_summary": "D-Asp (1-30 mM) reduced cell membrane permeability and suppressed the expression of pyroptosis-related markers (NLRP3, caspase-1, GSDMD, IL-1\u03b2, IL-18) in HGFs, indicating competitive antagonism against HMGB1. The study suggests D-Asp may help prevent pyroptosis and treat peri-implantitis.", "population_specificity": "Human gingival fibroblasts (HGFs) in vitro.", "effective_dosage": "1 mM, 10 mM, and 30 mM D-Asp.", "study_duration": "24-hour pretreatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:25.638370+00:00"}
{"study_id": 11862, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of the ROS-TXNIP-NLRP3-NR2B pathway in type 2 diabetic neuropathic pain (DNP) and the potential therapeutic effects of targeting this pathway.", "results_summary": "The study found that spinal ROS contributes to type 2 DNP via the TXNIP-NLRP3-NR2B pathway, and interventions like ROS scavenger PBN or TXNIP knockdown alleviated nociceptive hypersensitivity and reduced related protein levels in DNP rats and cell cultures.", "population_specificity": "Male Sprague-Dawley rats with induced type 2 diabetes and diabetic neuropathic pain, and BV2/PC12 cells in high-glucose conditions.", "effective_dosage": "PBN (100 mg\u00b7kg\u207b\u00b9\u00b7d\u207b\u00b9), TXNIP siRNA (10 \u03bcg/d)", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:25.952905+00:00"}
{"study_id": 11865, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of NMDA receptors, specifically through D-Aspartic Acid-related mechanisms, in heat-sensitization response and its impact on moxibustion efficacy for cerebral infarct rehabilitation.", "results_summary": "Inhibition of NMDA receptors with CPP significantly reduced heat-sensitization response and negatively affected moxibustion's rehabilitation efficacy in cerebral infarct rats, suggesting NMDA receptor activation plays a positive role in ischemic stroke recovery.", "population_specificity": "Cerebral infarct rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:26.303236+00:00"}
{"study_id": 11866, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the NMDAR/NO pathway in the anticonvulsive effects of lenalidomide on PTZ-induced seizures in mice.", "results_summary": "Lenalidomide at 10 and 20 mg/kg significantly elevated PTZ-induced seizure thresholds. The anticonvulsive effects were reversed by NO synthase inhibitors and the NMDAR antagonist MK-801, but not by the NMDAR agonist D-serine.", "population_specificity": "NMRI mice", "effective_dosage": "5, 10, 20, and 50 mg/kg (intraperitoneal)", "study_duration": "Acute administration (1 hour before PTZ)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:27.084283+00:00"}
{"study_id": 11867, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-Aspartic Acid (D-Asp) could protect against the toxic effects of ethane dimethane sulfonate (EDS) on rat testis, particularly focusing on Leydig cell damage and oxidative stress.", "results_summary": "Pre-treatment with D-Asp prevented EDS-induced Leydig cell destruction, maintained normal testosterone levels, reduced oxidative stress (TBARS levels), and preserved testicular morphology and sperm production.", "population_specificity": "Male rats", "effective_dosage": "Not specified", "study_duration": "15 days pre-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:27.646172+00:00"}
{"study_id": 11868, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the incidence of ovarian dermoid cysts associated with paraneoplastic encephalitis syndrome due to NMDA receptor antibodies among women undergoing surgical resection of dermoid cysts.", "results_summary": "The study found that anti-NMDA receptor encephalitis is a rare complication (0.85%) of ovarian dermoid cysts, occurring in both younger and older women with varying cyst sizes. Both affected patients recovered without significant neurological sequelae after treatment.", "population_specificity": "Women who underwent surgical resection of pathology-proven ovarian dermoid cysts between 2008 and 2019.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:28.834295+00:00"}
{"study_id": 11869, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were investigating a rare case of anti-NMDA-R encephalitis in a patient with autoimmune polyendocrine syndrome type 3, not directly studying D-Aspartic Acid.", "results_summary": "The study reported a case of anti-NMDA-R encephalitis in a patient with autoimmune polyendocrine syndrome type 3, highlighting early detection and steroid pulse therapy leading to full recovery. No direct findings on D-Aspartic Acid were mentioned.", "population_specificity": "A 39-year-old patient with autoimmune polyendocrine syndrome type 3 and anti-NMDA-R encephalitis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:31.198559+00:00"}
{"study_id": 11870, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Zn2+ and H+ in NMDA receptor activity related to depression and develop a dual-color fluorescent probe (DNP) to monitor these changes in living mouse brains.", "results_summary": "The study found that the DNP probe successfully tracked synchronous increases in Zn2+ and H+ in PC12 cells under oxidative stress and revealed simultaneous reductions of Zn2+ and pH in the brains of mice with depression-like behaviors, suggesting NMDA receptor involvement.", "population_specificity": "Mice with depression-like behaviors and PC12 cells under oxidative stress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:34.246621+00:00"}
{"study_id": 11873, "supplement_id": 1064, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine the short-term effects of D-Aspartic Acid on serum biomarkers of the hypothalamic-pituitary-gonadal axis and athletic performance in male climbers.", "results_summary": "The study found that D-Aspartic Acid did not significantly affect testosterone, free testosterone, or luteinizing hormone levels, nor did it influence other parameters linked to athletic performance or health status. Only minor changes in sex hormone binding globulin and cortisol were observed, which were not treatment-specific.", "population_specificity": "Male climbers", "effective_dosage": "3 g/day", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:34.813565+00:00"}
{"study_id": 11871, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether NMDA (N-methyl-d-aspartic acid) induces brain edema and if low-intensity ultrasound (LIUS) or NMDAR antagonists can mitigate this effect.", "results_summary": "NMDA induced brain edema similar to oxygen-glucose deprivation (OGD), while DHPG did not. NMDAR antagonists (MK-801, ketamine) and LIUS effectively reduced edema by inhibiting NMDAR phosphorylation.", "population_specificity": "Rat hippocampal slices (in vitro model).", "effective_dosage": "Ultrasound administered at 30, 50, or 100 mW/cm\u00b2 for 20 minutes.", "study_duration": "20 minutes of ultrasound treatment before edema induction.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:35.299213+00:00"}
{"study_id": 11874, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to describe a case of anti-NMDA-R encephalitis associated with autoimmune polyglandular syndrome (APS) and explore potential shared autoimmune mechanisms.", "results_summary": "The study reported a case of a 58-year-old woman with APS and anti-NMDA-R encephalitis, showing clinical improvement after surgical removal of an adnexal mass and resolution of anti-NMDA-R antibodies post-surgery. The findings suggest a possible shared autoimmune pathophysiology between APS and anti-NMDA-R encephalitis.", "population_specificity": "A 58-year-old woman with Graves' disease, thyrotoxicosis, type 1 diabetes mellitus, and anti-NMDA-R encephalitis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:36.845564+00:00"}
{"study_id": 11872, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the effects of EGb 761 (a Ginkgo biloba extract) on GluN2B expression in the inferior colliculus following sodium salicylate-induced ototoxicity, not specifically D-Aspartic Acid.", "results_summary": "The study found that EGb 761 reduced GluN2B protein expression in the inferior colliculus compared to the sodium salicylate-only group, suggesting a regulatory role in salicylate-induced ototoxicity. No significant differences in auditory brainstem response thresholds were observed among groups.", "population_specificity": "Seven-week-old Sprague Dawley rats (n=24)", "effective_dosage": "EGb 761 administered orally at 40 mg/kg for 5 consecutive days; sodium salicylate injected at 350 mg/kg once.", "study_duration": "5 days (EGb 761) + single sodium salicylate injection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:36.895459+00:00"}
{"study_id": 11875, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a water-soluble lipopolymer (WSLP) in delivering siRNA targeting NR2B to PC12 cells and its potential to relieve chronic inflammatory pain in rats.", "results_summary": "WSLP effectively protected siRNA from degradation, showed low cytotoxicity, and significantly reduced NR2B transcriptional and protein levels by 50% and 55%, respectively. Intrathecal injection of WSLP/NR2B-siRNA complexes in rats significantly reduced NR2B protein expression (58%) and relieved inflammatory pain over 3-5 days.", "population_specificity": "PC12 cells and rats with chronic inflammatory pain.", "effective_dosage": "Not specified", "study_duration": "3-5 days post-injection", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:37.038040+00:00"}
{"study_id": 11876, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the protective effects of the N-methyl-D-aspartic acid receptor (NMDAR) antagonist, memantine, on SK-N-SH cell apoptosis caused by chronic ethanol exposure.", "results_summary": "Chronic ethanol exposure reduced neuronal cell viability and induced apoptosis in SK-N-SH cells, linked to increased intracellular calcium concentration via NMDAR expression. Memantine treatment reduced ethanol-induced apoptosis, suggesting potential for treating alcoholic dementia.", "population_specificity": "SK-N-SH human neuroblastoma cells (in vitro study).", "effective_dosage": "Memantine (4 \u00b5M).", "study_duration": "2 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:37.319969+00:00"}
{"study_id": 11877, "supplement_id": 1064, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether D-Aspartic Acid (DAA) could alter basal testosterone levels and affect training outcomes in resistance-trained men over 3 months.", "results_summary": "DAA supplementation did not change testosterone levels but led to a 16% reduction in estradiol. Both DAA and placebo groups showed similar improvements in strength and muscle hypertrophy, with no additional benefits from DAA.", "population_specificity": "Resistance-trained men aged 18-36 who had been training regularly for at least 2 years.", "effective_dosage": "6 g per day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:39.657517+00:00"}
{"study_id": 11878, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of repeated D-Aspartic Acid treatment on neuropathic pain, cognitive/emotional dysfunctions, \u03b2-amyloid protein accumulation, and steroid levels in a mouse model of chronic pain.", "results_summary": "D-Asp treatment reduced abnormal behaviors, normalized \u03b2-amyloid protein expression, and significantly increased steroid levels in the prefrontal cortex and hippocampus of neuropathic mice.", "population_specificity": "Mice with spared nerve injury (SNI)-induced neuropathic pain.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:42.541358+00:00"}
{"study_id": 11880, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of D-Aspartic Acid on sperm quality, fertility, and hatchability in male broiler breeders.", "results_summary": "D-Aspartic Acid at 200 mg/kg BW significantly improved fresh and post-thawed sperm quality, fertility, and hatchability compared to other doses, with no significant adverse effects on sperm viability.", "population_specificity": "Male broiler breeders (55-week-old roosters)", "effective_dosage": "0, 100, 200, or 300 mg/kg BW daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:43.377182+00:00"}
{"study_id": 11879, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the psychiatric aspects of anti-NMDAR encephalitis and present a case report of a patient with pure psychiatric manifestations of the disease.", "results_summary": "The study highlights that anti-NMDAR encephalitis often presents with psychiatric symptoms initially, leading to misdiagnosis and unnecessary antipsychotic treatment. Immune suppressive therapy was effective in most cases, though the connection between anti-NMDAR antibodies and psychotic disorders remains unclear.", "population_specificity": "Patients with anti-NMDAR encephalitis, particularly those presenting with psychiatric symptoms.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:43.441083+00:00"}
{"study_id": 11883, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to design and evaluate novel Pin1 inhibitors based on glutamic acid or aspartic acid scaffolds for potential cancer therapy.", "results_summary": "Glutamic acid derivatives with cycloalkylamino and phenylthiazole groups showed potent Pin1-inhibitory activity comparable to known inhibitor VER-1, with steric interactions of cyclic alkyl amine moieties enhancing inhibitory effects.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:45.126386+00:00"}
{"study_id": 11882, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of N-methyl-D-aspartic acid receptor 1 (NMDAR1) in NLRP3-mediated inflammatory damage following intracerebral hemorrhage (ICH).", "results_summary": "The study found that NMDAR1 expression and phosphorylation increased after ICH, promoting NLRP3 inflammasome activation and IL-1b release, which was reversed by the NMDAR antagonist MK801. Hemin treatment enhanced NMDAR1-NLRP3 binding, suggesting NMDAR1's pivotal role in inflammatory damage.", "population_specificity": "Mice with induced intracerebral hemorrhage and cultured microglial cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:46.720841+00:00"}
{"study_id": 11881, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of miR-217 in vascular smooth muscle cell (VSMC) phenotype transition under homocysteine exposure and its effect on atherosclerotic plaque formation, with NMDAR as a potential target.", "results_summary": "The study found that miR-217 mimic inhibited VSMC proliferation and migration under homocysteine treatment, down-regulated NMDAR protein expression, and restored CREB-PGC-1\u03b1 signaling, while miR-217 inhibitor had opposing effects. PGC-1\u03b1 restoration suppressed VSMC proliferation via NOX1 degradation and ROS reduction.", "population_specificity": "Human aortic vascular smooth muscle cells (HA-VSMCs) and rat aortic VSMCs.", "effective_dosage": "Homocysteine doses ranged from 0 to 8 \u00d7 10^(-4) mol/L.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:47.075623+00:00"}
{"study_id": 11884, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the ketamine dose-dependency of ketamine-induced cystitis (KC) in a rat model, focusing on urinary tract dysfunction.", "results_summary": "The study found that higher ketamine doses led to decreased voiding intervals and bladder capacity, increased fibrosis, and submucosal apoptosis, suggesting fibrosis plays a key role in KC.", "population_specificity": "Female Sprague-Dawley rats (10-week-old)", "effective_dosage": "1, 5, 10, 25, and 50 mg/kg ketamine intravenous injection", "study_duration": "Two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:47.301844+00:00"}
{"study_id": 11885, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether agmatine protects M\u00fcller cells from glucose-induced damage and to explore the underlying mechanisms, including the role of NMDA receptor suppression.", "results_summary": "Agmatine reduced lactate dehydrogenase activity and tumor necrosis factor-\u03b1 mRNA expression, inhibited glucose-induced apoptosis, and suppressed MAPK phosphorylation in M\u00fcller cells. These protective effects were blocked by NMDA, suggesting agmatine's benefits are mediated via NMDA receptor suppression.", "population_specificity": "M\u00fcller cells (retinal glial cells) exposed to high glucose concentrations in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:49.420436+00:00"}
{"study_id": 11886, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of modulating spinal NMDAR activation (potentially involving D-Aspartic Acid) on morphine-induced analgesic tolerance.", "results_summary": "The study suggests chronic morphine treatment may worsen spinal NMDAR activation and sensitization, potentially accelerating morphine tolerance; NMDAR inhibition could alleviate tolerance development.", "population_specificity": "Not specified (likely animal or preclinical model based on context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:50.187415+00:00"}
{"study_id": 11887, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the metabolism and disposition of lanicemine (AZD6765), an NMDA channel blocker, in healthy male subjects after a single intravenous dose.", "results_summary": "Lanicemine was found to be a low-clearance compound, with the unchanged drug and metabolites predominantly eliminated via urinary excretion. The major circulating component was lanicemine itself, with 10 metabolites identified, none exceeding 4% of total radioactivity in plasma or urine.", "population_specificity": "Six healthy male subjects", "effective_dosage": "Single intravenous infusion of 150 mg [(14)C]-lanicemine", "study_duration": "Single dose (no duration specified beyond sample collection)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:52.384750+00:00"}
{"study_id": 11888, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether atorvastatin (ATV) treatment affects the GluN1 and GluN2B subunits of the N-methyl-D-aspartic acid receptor in the somatosensory cerebral cortex following ischemia, and its role in neuroprotection.", "results_summary": "ATV treatment improved neurological recovery, prevented neuronal damage, restored protein staining, and prevented spatial learning and memory deficits post-ischemia. It also preserved GluN1/PSD-95 and GluN2B/PSD-95 colocalization and BDNF levels, with GluN2B inhibition reversing these benefits.", "population_specificity": "Male Wistar rats subjected to cerebral ischemia-reperfusion or sham operation.", "effective_dosage": "10 mg/kg every 24 hours for 3 consecutive days.", "study_duration": "3 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:53.323123+00:00"}
{"study_id": 11892, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to summarize the clinical manifestations, immunotherapeutic response, and prognosis of anti-NMDA receptor encephalitis.", "results_summary": "The study found that anti-NMDA receptor encephalitis presents with psychiatric symptoms, memory loss, epilepsy, and movement disorders, and timely treatment can yield a favorable prognosis.", "population_specificity": "Seven patients with anti-NMDA receptor encephalitis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:54.584112+00:00"}
{"study_id": 11889, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study investigated the effects of TRPV1 agonists (capsaicin and SA13353) on retinal injury induced by NMDA in rats, not D-Aspartic Acid.", "results_summary": "The study found that capsaicin and SA13353 almost completely prevented retinal ganglion cell loss induced by NMDA in rats, with protection mediated via TRPV1, CGRP, and tachykinin NK1 receptors.", "population_specificity": "Male Sprague-Dawley rats and B6.Cg-TgN(Thy1-CFP)23Jrs/J transgenic mice.", "effective_dosage": "Capsaicin (5.0 nmol/eye intravitreally), SA13353 (10mg/kg intraperitoneally).", "study_duration": "Evaluated at 7 days post-NMDA injection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:56.241069+00:00"}
{"study_id": 11890, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the neuroprotective and anti-inflammatory effects of simvastatin, particularly its interaction with NMDAR1 (N-methyl-D-aspartic acid receptor 1), in a Parkinson's disease cell model.", "results_summary": "Simvastatin reduced 6-OHDA-induced increases in LDH, glutamate, and proinflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6) in PC12 cells, with effects comparable to NMDAR1 silencing. This suggests NMDAR1 modulation may underlie simvastatin's anti-inflammatory mechanisms.", "population_specificity": "PC12 (pheochromocytoma-12) cells treated with 6-OHDA to model Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:56.621628+00:00"}
{"study_id": 11891, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether electroacupuncture (EA) could modulate NMDA receptor expression (specifically NR 1 and NR 2 B subunits) in the spinal cord of rats with chronic constrictive injury (CCI) to alleviate neuropathic pain.", "results_summary": "EA significantly downregulated NR 1 protein and mRNA expression in the spinal cord of CCI rats, correlating with pain relief, but had no significant effect on NR 2 B expression.", "population_specificity": "Male Sprague-Dawley (SD) rats with induced chronic constrictive injury (CCI) of the sciatic nerve.", "effective_dosage": "EA stimulation at 2 Hz, 1-3 mA (increasing 1 mA every 10 min) for 30 min daily.", "study_duration": "10 days (from day 11 to day 20 post-modeling).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:57.782296+00:00"}
{"study_id": 11893, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanisms by which endogenous IL-1\u03b2 alters glutamatergic synaptic transmission in the spinal dorsal horn in rats with neuropathic pain.", "results_summary": "The study found that endogenous IL-1\u03b2 enhances glutamate release from primary afferent terminals and non-NMDA glutamate receptor activities in postsynaptic neurons in the spinal dorsal horn, mediated by the MyD88 and neutral sphingomyelinase/ceramide signaling pathways.", "population_specificity": "Rats with neuropathic pain induced by ligation of the L5 spinal nerve.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:58.597162+00:00"}
{"study_id": 11894, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular mechanisms by which NMDA receptor activation affects GABAA receptor plasticity, specifically focusing on \u03b4 subunit expression in hippocampal neurons.", "results_summary": "Prolonged NMDA treatment reduced surface and total \u03b4 subunit expression in hippocampal neurons, diminished tonic current, and decreased neurosteroid modulation, while synaptic inhibition remained unaffected. These effects were mediated by Ca\u00b2\u207a entry and ERK1/2 activation.", "population_specificity": "Cultured hippocampal neurons from epileptic animals.", "effective_dosage": "10 \u03bcM NMDA", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:35:59.222327+00:00"}
{"study_id": 11896, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to examine the disease course and treatment outcomes in a case of NMDA receptor antibody-associated encephalitis with delayed therapy.", "results_summary": "The study found that recovery in NMDA receptor encephalitis can be severely delayed and non-linear, with a surprising recovery occurring 18 months after rituximab treatment and 30 months after symptom onset. Serum antibodies were unreliable markers of disease activity.", "population_specificity": "A 16-year-old girl with NMDA receptor antibody-associated encephalitis.", "effective_dosage": "Not specified", "study_duration": "36-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:02.018517+00:00"}
{"study_id": 11897, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether intrinsically photosensitive retinal ganglion cells (ipRGCs) are resistant to NMDA-induced excitotoxicity.", "results_summary": "The study found that ipRGCs were resistant to NMDA-induced excitotoxicity, unlike other retinal ganglion cells, and this resistance did not depend on PI3K/AKT or JAK/STAT signaling pathways.", "population_specificity": "Mice", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:02.149535+00:00"}
{"study_id": 11895, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether KN-93, a calmodulin-dependent protein kinase II inhibitor, could mitigate N-methyl-D-aspartic acid-induced neuronal injury in rat cortical neurons.", "results_summary": "KN-93 treatment increased cell activity, reduced apoptosis, decreased lactate dehydrogenase leakage, and lowered intracellular Ca(2+) concentrations. The effect was dose-dependent, with 1.0 \u03bcM KN-93 showing the most significant neuroprotective impact, likely due to downregulation of caspase-3 and calmodulin-dependent protein kinase II expression.", "population_specificity": "Primary cultured cerebral cortical neurons from Sprague-Dawley neonatal rats.", "effective_dosage": "0.25, 0.5, and 1.0 \u03bcM KN-93.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:02.360833+00:00"}
{"study_id": 11898, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether gintonin, a component of ginseng, enhances NMDA receptor activity and long-term potentiation (LTP) via LPA receptor activation, potentially explaining ginseng's memory-improving effects.", "results_summary": "Gintonin enhanced NMDA receptor-mediated ion currents and LTP in a concentration-dependent manner, effects blocked by LPA receptor antagonists and other inhibitors, suggesting a role in memory-related brain functions.", "population_specificity": "Xenopus oocytes expressing rat NMDA receptors and cultured hippocampal neurons/rat hippocampal slices.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:05.077120+00:00"}
{"study_id": 11900, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers investigated the protective mechanism of ACTH against brain damage in an infantile spasm rat model induced by N-methyl-D-aspartate (NMDA).", "results_summary": "Prenatal stress exposure worsened seizures, while ACTH treatment reduced and delayed seizure onset. Key proteins involved in cytoskeleton, synapses, and energy metabolism were identified as part of ACTH's mechanism.", "population_specificity": "Neonate rats and five infantile spasm patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:05.886576+00:00"}
{"study_id": 11899, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether D-Aspartic Acid (D-Asp) modulates sex hormone levels in male frogs by regulating P450 aromatase activity and its effects on testosterone and estradiol levels during different reproductive phases.", "results_summary": "D-Asp administration increased brain P450 aromatase expression, estradiol levels, and ER\u03b1 expression while decreasing testosterone and androgen receptor expression in reproductive-phase frogs, but had no effect in post-reproductive frogs. The findings suggest D-Asp plays a role in regulating estradiol levels in the frog brain.", "population_specificity": "Male frogs during reproductive and post-reproductive phases of the breeding cycle.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:06.151547+00:00"}
{"study_id": 11902, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the influence of NMDA receptor blockade (via memantine) on collagen-induced arthritis in mice, focusing on its potential to modulate inflammation and immune responses.", "results_summary": "Memantine significantly improved arthritis outcomes by reducing synovitis and erosions, while upregulating regulatory T cells. Other GluR antagonists (AIDA and KA) showed no effect.", "population_specificity": "DBA/1 mice with collagen-induced arthritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:06.758077+00:00"}
{"study_id": 11901, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of pre- and postsynaptic NMDA receptors in controlling increased glutamatergic input in the spinal cord induced by chronic systemic morphine administration.", "results_summary": "Chronic morphine increased glutamatergic input in the spinal cord, which was attenuated by blocking NMDARs and inhibiting PKC. Postsynaptic NMDAR activity was impaired by morphine, while presynaptic activity was potentiated, contributing to opioid hyperalgesia and analgesic tolerance.", "population_specificity": "Rat spinal cord dorsal horn neurons", "effective_dosage": "Not specified", "study_duration": "Chronic administration (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:07.299908+00:00"}
{"study_id": 11905, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between nitric oxide-mediated cell death in human periodontal ligament fibroblasts and the NMDA receptor antagonist MK801.", "results_summary": "The study found that nitric oxide (via SNP) reduced cell viability in a concentration-dependent manner and increased apoptotic markers (Bax, cytochrome c). NMDA receptor antagonist MK801 showed a synergistic effect with SNP in inducing apoptosis.", "population_specificity": "Human periodontal ligament fibroblasts (PDLFs)", "effective_dosage": "SNP concentrations ranged from 0 to 4 mM; MK801 was used at 200 \u00b5M.", "study_duration": "16 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:11.373011+00:00"}
{"study_id": 11903, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were comparing the antinociceptive effects and side effects of three N-methyl-D-aspartate receptor antagonists (ketamine, norketamine, and traxoprodil) in rat models of acute and chronic pain.", "results_summary": "All three antagonists showed dose-dependent antinociception in acute pain and relief of chronic pain symptoms, with ketamine being the most potent. Traxoprodil demonstrated a clear separation between therapeutic effects and side effects, making it a promising alternative to ketamine for chronic neuropathic pain.", "population_specificity": "Rat models of acute antinociception and chronic neuropathic pain (spared nerve injury).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 hours per day for 5 consecutive days in the chronic pain model.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:11.922307+00:00"}
{"study_id": 11904, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not investigate D-Aspartic Acid; it focuses on the effects of cannabinoid receptor agonists (specifically CB2 receptor activation) on cancer pain and NR2B receptor expression in mice.", "results_summary": "The study found that intrathecal administration of the CB2 receptor agonist JWH015 attenuated tumor-evoked pain behaviors in mice, likely by reducing NR2B-dependent activity in the spinal cord. The effect was dose-dependent and blocked by the CB2 antagonist AM630.", "population_specificity": "C(3)H/Hej mice with induced bone cancer pain.", "effective_dosage": "JWH015 (0.5, 1, and 2 \u03bcg) administered intrathecally.", "study_duration": "Assessments were made up to 72 hours post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:12.317855+00:00"}
{"study_id": 11906, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to investigate whether curcumin exhibited neuroprotective and antioxidant activity via enhanced RANTES expression by astrocytes in cortical neuron cultures, not D-Aspartic Acid.", "results_summary": "The study found that curcumin enhanced RANTES expression in astrocytes, inhibited iNOS expression, and improved neuronal survival in NMDA toxicity and long-term cultures via PI3K/MAPK pathways. No findings related to D-Aspartic Acid were reported.", "population_specificity": "Primary cultures of cortical neurons and astrocytes from Sprague-Dawley rats.", "effective_dosage": "Not specified for D-Aspartic Acid.", "study_duration": "Not specified for D-Aspartic Acid.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:14.103606+00:00"}
{"study_id": 11907, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the molecular mechanisms by which cholesterol modulates A\u03b2-induced Tau cleavage in cultured hippocampal neurons, focusing on the role of N-methyl-d-aspartic acid receptors.", "results_summary": "The study found that cholesterol reduction in mature neurons decreased NR1 subunit membrane presence and increased large NR1, NR2A, and NR2B subunit clusters, suggesting synaptic changes underlie cholesterol's modulation of A\u03b2-induced toxicity. N-methyl-d-aspartic acid receptor inhibitors were shown to play an essential role in cholesterol-mediated A\u03b2-dependent calpain activity and Tau cleavage.", "population_specificity": "Cultured hippocampal neurons (in vitro cellular model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:15.302924+00:00"}
{"study_id": 11908, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of stress and stress-alcohol interactions on NMDA receptors in the brains of WKY and WIS rat strains.", "results_summary": "The study found that voluntary alcohol consumption increased NMDA receptors in the hippocampus and basolateral amygdala in both rat strains, while chronic stress increased NMDA receptors in the prefrontal cortex, caudate putamen, and nucleus accumbens in WKY rats. Alcohol co-treatment with stress reversed stress-induced NMDA receptor changes in the basolateral amygdala but not in the hippocampus.", "population_specificity": "Wistar-Kyoto (WKY) and Wistar (WIS) rat strains.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:15.429004+00:00"}
{"study_id": 11909, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the distribution of D-aspartic acid (D-Asp) and related enzyme activities in frog tissues, as well as the effects of D-Asp administration on these enzymes.", "results_summary": "High concentrations of free D-Asp were found in frog testes, liver, and Harderian gland. D-Asp administration increased D-AspO activity but not D-AAO or L-AAO, suggesting D-AspO plays a role in regulating D-Asp levels.", "population_specificity": "Frog (Rana esculenta) tissues", "effective_dosage": "2.0 micromol/g body weight (i.p. injection)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:15.618301+00:00"}
{"study_id": 11910, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-Aspartic Acid (D-Asp) plays a role in learning and memory processes in rats.", "results_summary": "Oral administration of sodium D-aspartate significantly improved cognitive performance in rats, as evidenced by faster platform location in the Morris water maze. Treated rats showed a 2.7-fold increase in hippocampal D-Asp levels, correlating with enhanced cognitive capability.", "population_specificity": "Rats (24 total, divided into treated and control groups).", "effective_dosage": "40 mM sodium D-aspartate (specific frequency not detailed).", "study_duration": "12-16 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:16.517444+00:00"}
{"study_id": 11912, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to study the relationship between learning and memory ability (LMA) and hippocampal NMDA expression in burn rats with depression.", "results_summary": "The study found that burn combined with depression reduced LMA, possibly due to decreased NMDA expression in the dentate gyrus. Escape latency in the water maze test was prolonged in burn and depression groups compared to controls.", "population_specificity": "Wistar rats (burn, depression, burn + depression, and healthy control groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:19.875620+00:00"}
{"study_id": 11911, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 65, "study_goal": "The researchers sought to describe hospice medical directors' practice patterns and experiences regarding the use and discontinuation of NMDA receptor antagonists (including memantine, an NMDA antagonist related to D-Aspartic Acid) in end-stage dementia patients.", "results_summary": "A subset of hospice medical directors reported clinical benefits from NMDA receptor antagonists, including stabilization of cognition (22%), reduced challenging behaviors (28%), and improved caregiver outcomes (20%). However, discontinuation led to accelerated cognitive/functional decline (30%) and challenging behaviors (32%) in some patients.", "population_specificity": "Hospice patients with end-stage dementia meeting Medicare hospice criteria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:20.818373+00:00"}
{"study_id": 11913, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between D-Aspartic Acid and testicular activity, specifically its effects on testosterone levels, c-kit receptor protein, tyrosine kinase activity, and PCNA in the reproductive cycle of Podarcis s. sicula.", "results_summary": "The study found that D-Aspartic Acid significantly accumulated in the testes, increasing testosterone levels, enhancing c-kit receptor protein expression, and activating tyrosine kinases. It also induced PCNA expression, suggesting a functional relationship between these molecules mediated by D-Asp.", "population_specificity": "Lizard (Podarcis s. sicula) testes during the reproductive cycle.", "effective_dosage": "2.0 micromol/g body weight (single injection).", "study_duration": "Observations made up to 15 hours post-injection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:22.021049+00:00"}
{"study_id": 11915, "supplement_id": 1064, "safety_score": "30", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine the extent of oxidative stress induced by D-Aspartic Acid in the testis of prepubertal rats.", "results_summary": "D-Aspartic Acid significantly increased oxidative stress markers (reactive oxygen species, malondialdehyde, hydroperoxide) and altered mitochondrial function in the testis, suggesting potential oxidative perturbations.", "population_specificity": "Prepubertal rats", "effective_dosage": "100 and 500 mg/kg body weight per day, intraperitoneal", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:23.026190+00:00"}
{"study_id": 11914, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of the NMDAR antagonist MK-801 on NMDAR subunit expression in parvalbumin-immunoreactive interneurons and pyramidal neurons in the prefrontal cortex of young adult rats.", "results_summary": "MK-801 induced distinct, dose-dependent changes in NMDAR subunit expression in PV-ir interneurons versus pyramidal neurons, with biphasic responses in interneurons and inverted-U responses in the PFC overall. Protein expression changes aligned with mRNA findings, suggesting differential regulation of NMDAR function in these neuronal populations.", "population_specificity": "Young adult rat prefrontal cortex (PFC)", "effective_dosage": "Not specified (low, medium, and high doses of MK-801 used)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:23.714732+00:00"}
{"study_id": 11917, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the intraneuronal interaction between glutamate and dopamine systems, focusing on implications for psychiatric disorder treatments.", "results_summary": "The abstract discusses the integration of dopamine and glutamate signaling pathways in psychiatric conditions like schizophrenia and addiction but does not mention D-Aspartic Acid specifically.", "population_specificity": "Not specified (focus on neurotransmitter systems, not a human or animal population).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article, not an intervention study).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:23.765695+00:00"}
{"study_id": 11916, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine frequency oscillations in mice under NMDAR hypofunction and dopaminergic hyperactivity, modeling schizophrenia, to understand the role of these pathways in cognitive deficits.", "results_summary": "Ketamine increased basal gamma power and decreased evoked theta power, mimicking schizophrenia-like EEG abnormalities. Antipsychotics did not fully reverse these effects, suggesting NMDAR hypofunction contributes to deficits beyond dopaminergic pathways.", "population_specificity": "Mice (animal model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:24.050524+00:00"}
{"study_id": 11918, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of mGluR5 in schizophrenia-related behaviors and the effects of clozapine on these behaviors in mGluR5 knockout mice.", "results_summary": "The study found that mGluR5 knockout mice exhibited schizophrenia-like behaviors, including hyperlocomotion, reduced prepulse inhibition, and spatial memory deficits. Clozapine treatment reversed some of these behaviors but did not improve spatial memory performance.", "population_specificity": "mGluR5 knockout mice", "effective_dosage": "Not specified", "study_duration": "Chronic administration (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:25.004990+00:00"}
{"study_id": 11919, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the use of acetylcholinesterase inhibitors (AChEI) and memantine among hospice patients with dementia and identify factors associated with their use.", "results_summary": "The study found that 21% of hospice patients with dementia were prescribed AChEI and/or memantine, with donepezil being the most common. Factors like gender, hospice length of stay, and care setting influenced prescription rates.", "population_specificity": "Persons over 65 admitted to hospice with a primary diagnosis of dementia (n=10,065).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:28.416403+00:00"}
{"study_id": 11920, "supplement_id": 1064, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the oxidative induction response of D-aspartic acid (DA) in prepubertal rat testis and its potential modulation by L-arginine (LA).", "results_summary": "DA significantly increased oxidative stress markers (ROS and MDA) in rat testis preparations, which was further enhanced by inhibitors of peroxide-metabolizing enzymes. L-arginine reduced oxidative stress and suppressed DA-induced effects, suggesting an antagonistic interaction.", "population_specificity": "Prepubertal rat testis (homogenates, explants, and cell suspensions).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "L-arginine suppressed DA-induced oxidative stress; iron, 3-amino triazole, and mercaptosuccinate potentiated DA's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:30.383233+00:00"}
{"study_id": 11921, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a new animal model of infantile spasms using prenatal betamethasone and postnatal NMDA exposure to study the brain structures involved and test adrenocorticotropin therapy.", "results_summary": "Prenatal betamethasone sensitized rats to NMDA-induced spasms, which were responsive to adrenocorticotropin therapy. The spasms involved limbic areas, hypothalamus, and brainstem, with EEG patterns resembling human infantile spasms.", "population_specificity": "Rat offspring exposed prenatally to betamethasone and postnatally to NMDA.", "effective_dosage": "Not specified (NMDA administered on postnatal day 15).", "study_duration": "Single NMDA administration on postnatal day 15.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:31.256308+00:00"}
{"study_id": 11923, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of NMDA receptor-mediated phosphorylation of SCG10 in neuronal plasticity and microtubule dynamics.", "results_summary": "The study found that NMDA receptor activation (via kainate treatment) induced rapid phosphorylation of SCG10 at Ser73, mediated by Erk2, suggesting a link between neural activity and microtubule regulation in dendrites.", "population_specificity": "Primary cultured hippocampal neurons and adult hippocampal tissues (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Acute response measured within 15-60 minutes after kainate treatment.", "interactions": "MK-801 (NMDA receptor antagonist) blocked the phosphorylation response.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:31.794191+00:00"}
{"study_id": 11924, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the presence and concentration of D-aspartic acid (D-Asp) in human seminal plasma and spermatozoa among fertile and infertile donors, and its potential role in male fertility.", "results_summary": "The study found that D-Asp concentration was significantly reduced in oligoasthenoteratospermic and azoospermic donors compared to normospermic donors, suggesting a potential link between D-Asp levels and male fertility. No other D-amino acids were present in significant concentrations in seminal plasma or spermatozoa.", "population_specificity": "Ten normospermic, 10 oligoasthenoteratospermic, and 10 azoospermic (nonobstructive) men.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:33.400323+00:00"}
{"study_id": 11922, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Akt activity in retinal ganglion cell death induced by N-Methyl-D-Aspartic acid (NMDA) in rats and explore potential neuroprotective mechanisms involving BDNF and phosphorylated Akt.", "results_summary": "NMDA injection reduced phosphorylated Akt in retinal ganglion and amacrine cells, leading to apoptosis and cell death. BDNF administration prevented Akt dephosphorylation and significantly reduced NMDA-induced cell death, suggesting Akt's role in neuroprotection.", "population_specificity": "Sprague-Dawley rats (n=125)", "effective_dosage": "1, 10, 50, 100, or 200 mM NMDA (2 \u00b5L intravitreal injection)", "study_duration": "Acute (effects measured at 1 h, 6 h, and 7 days post-injection)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:33.792485+00:00"}
{"study_id": 11927, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to determine whether memantine (an NMDA receptor antagonist) could reduce chronic phantom limb pain (PLP) and associated cortical reorganization.", "results_summary": "The study found that memantine (30 mg/d) had no effect on the intensity of chronic PLP or cortical reorganization compared to placebo. The results suggest memantine is ineffective for treating chronic PLP at the studied dosage.", "population_specificity": "8 patients with chronic phantom limb pain", "effective_dosage": "30 mg per day", "study_duration": "4 weeks per treatment period (placebo-controlled crossover trial)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:37.311358+00:00"}
{"study_id": 11928, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers investigated the effect of isoflurane on NMDA-gated currents in cortical neurons and HEK 293 cells, focusing on subunit-dependent sensitivity (NR2A vs. NR2B).", "results_summary": "Isoflurane inhibited NMDA-gated currents more effectively in NR2B-containing receptors than NR2A-containing receptors, with tachyphylaxis observed after brief exposure. Hooked tail currents were induced by isoflurane in both cultured neurons and HEK 293 cells.", "population_specificity": "Cultured cortical neurons and HEK 293 cells with recombinant NMDA receptors.", "effective_dosage": "Not specified", "study_duration": "1-4 weeks in culture", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:39.512734+00:00"}
{"study_id": 11930, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to investigate regional differences in the feeding stimulatory effects of hypothalamically delivered N-methyl-D-aspartate (NMDA) in rats.", "results_summary": "NMDA reliably stimulated feeding when delivered to the tuberal lateral hypothalamus (tLH) in satiated rats, increasing food intake and time spent eating, but had no effect in other hypothalamic regions. NMDA also altered behaviors like resting, grooming, and alertness depending on the infusion site.", "population_specificity": "Satiated rats", "effective_dosage": "660 microM intraprobe", "study_duration": "50 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:39.638013+00:00"}
{"study_id": 11929, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to develop an improved method for detecting NMDA in biological tissues and compare its levels across various animal phyla.", "results_summary": "The study devised a sensitive HPLC-based method to measure NMDA in tissues, detecting levels as low as 5-10 picomol/assay, with additional purification required for concentrations below 1nmol/g. The method was applied to compare NMDA levels in neuroendocrine and other tissues across multiple animal species.", "population_specificity": "Various animal phyla, from mollusks to mammals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:40.179461+00:00"}
{"study_id": 11932, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of NMDA (N-methyl-D-aspartic acid) on metaphit-induced audiogenic seizures in rats to develop a suitable animal model of seizures.", "results_summary": "NMDA alone did not provoke seizures but induced a proconvulsive brain state and stereotyped behavior. It also potentiated metaphit-induced audiogenic seizures in some rats.", "population_specificity": "Adult male Wistar albino rats", "effective_dosage": "Subconvulsive NMDA dose (specific amount not provided)", "study_duration": "Testing occurred over 8-30 hours", "interactions": "Potentiation of metaphit-induced seizures noted", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:42.167494+00:00"}
{"study_id": 11931, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of D-Aspartic Acid in ovarian steroidogenesis and its effect on aromatase activity in the lizard Podarcis s. sicula.", "results_summary": "D-Aspartic Acid was found to decrease testosterone and increase oestradiol levels in the ovary and plasma, while other amino acids had no effect. It also significantly increased aromatase activity, enhancing the conversion of testosterone to oestradiol.", "population_specificity": "Female lizards (Podarcis s. sicula) during reproductive phases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:42.248831+00:00"}
{"study_id": 11926, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of inflammatory mechanisms and iNOS induction in NMDA-induced striatal excitotoxicity in rats.", "results_summary": "NMDA administration caused neuronal loss, glial activation, and iNOS expression, which were partially mitigated by the iNOS inhibitor aminoguanidine (AG). AG also prevented nigral cell loss and AMPH-induced rotation.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "24 hours and 30 days post-NMDA lesion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:43.307378+00:00"}
{"study_id": 11933, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether glutamate and NMDA receptors in human osteoblastic cell lines are functional and their role in bone cell signaling.", "results_summary": "Glutamate and NMDA induced significant increases in membrane currents in osteoblastic cells, which were partially blocked by NMDA receptor antagonists. The results suggest glutamate plays a role in bone cell signaling.", "population_specificity": "Human osteoblastic cell lines (MG63 and SaOS-2)", "effective_dosage": "100 micromol/L (NMDA, MK801, R-CPP)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:45.518166+00:00"}
{"study_id": 11935, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to analyze the role of NMDA and kainic acid in prolactin (PRL) secretion in females with varying serum PRL concentrations.", "results_summary": "NMDA stimulated PRL release in cyclic females, independent of serum PRL levels, while kainic acid was only inhibitory. NMDA and kainic acid had differing effects based on neonatal hormone exposure and blocked stress-induced PRL secretion.", "population_specificity": "Female rats (hypoprolactinaemic, hyperprolactinaemic, and prepubertal).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Domperidone (a dopamine antagonist) blocked inhibitory effects of NMDA and kainic acid.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:48.147804+00:00"}
{"study_id": 11934, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the regulatory mechanisms of GnRH gene expression by NMDA in immortalized hypothalamic GnRH neurons (GT1-1 cells).", "results_summary": "NMDA transiently stimulated GnRH mRNA levels at lower concentrations (10 and 100 microM) but not at higher concentrations (1 and 10 mM). The effect was mediated by the NO-Jun signal transduction pathway, with c-jun activation playing a key role in transcriptional activation of GnRH gene expression.", "population_specificity": "Immortalized hypothalamic GnRH neurons (GT1-1 cells).", "effective_dosage": "10 microM, 100 microM, 1 mM, and 10 mM NMDA.", "study_duration": "Transient effects observed at 2 hours post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:49.116850+00:00"}
{"study_id": 11936, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the localization of D-aspartic acid (D-Asp) in rat testis and its relationship with spermatogenesis using immunohistochemical and biochemical techniques.", "results_summary": "The study found D-Asp localized primarily in the cytoplasm of germ cells, especially elongate spermatids, with varying intensity based on germ cell composition. Toxicant-induced cell destruction confirmed D-Asp's role in spermatogenesis, showing significant decreases in D-Asp levels correlated with specific germ cell depletion.", "population_specificity": "Male rats (young and adult)", "effective_dosage": "Not specified", "study_duration": "Variable (3-20 days post-toxicant administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:49.997217+00:00"}
{"study_id": 11937, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of ARL 15896AR (a D-Aspartic Acid receptor antagonist) in animal models of anoxia and ischemia.", "results_summary": "ARL 15896AR extended survival during hypoxia, protected hippocampal neurons in global ischemia, and reduced cortical infarct volume in focal ischemia, though it showed mixed results in other models and only partial prevention of motor impairment.", "population_specificity": "Rodents (rats and gerbils) with induced anoxia, global ischemia, or focal ischemia.", "effective_dosage": "Not specified (oral and intraperitoneal dosing mentioned).", "study_duration": "Varied by model (e.g., 20 min ischemia, 2 hr occlusion plus 22 hr reflow, up to 42 days post-MCAO).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:52.354687+00:00"}
{"study_id": 11939, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether metapramine exhibits antiglutamatergic activity by interfering with the NMDA receptor complex, specifically at the PCP site.", "results_summary": "Metapramine inhibited the binding of [3H]TCP in the presence of NMDA and glycine (IC50 = 1.4 microM) and reduced NMDA-evoked cGMP levels in rat cerebellar slices (IC50 = 13 microM), suggesting it is a low-affinity NMDA receptor antagonist.", "population_specificity": "Rat cortical membranes and neonatal rat cerebellar slices (in vitro study).", "effective_dosage": "Micromolar range (IC50 values: 1.4 microM for [3H]TCP binding inhibition, 13 microM for cGMP reduction).", "study_duration": "Not specified (in vitro study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:53.605326+00:00"}
{"study_id": 11938, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of N-methyl-D-aspartic acid (NMDA) receptors and phospholipase A2 (PLA2) in the induction of cyclooxygenase-2 (COX-2) after spreading depression (SD) and focal ischemia.", "results_summary": "The study found that COX-2 expression was rapidly increased after SD and transient focal ischemia, primarily in cortical neurons, and this induction was mediated by NMDA receptor activation and PLA2. MK-801, an NMDA receptor antagonist, blocked SD and reduced COX-2 induction, while PLA2 inhibitors preserved SD propagation but still reduced COX-2 expression.", "population_specificity": "Rat models for SD and focal ischemia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "MK-801 (NMDA receptor antagonist), dexamethasone, quinacrine (PLA2 inhibitors), NBQX (AMPA/kainate receptor antagonist), indomethacin, diclofenac (COX inhibitors), NG-nitro-L-arginine methyl ester (NO synthase inhibitor)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:54.290590+00:00"}
{"study_id": 11925, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to clarify the role of spinal N-methyl-D-aspartate (NMDA) receptors in the development and maintenance of secondary mechanical allodynia induced by capsaicin.", "results_summary": "The study found that intrathecal injection of MK801, an NMDA receptor antagonist, had no effect on the development or maintenance of secondary mechanical allodynia induced by capsaicin. Spinal ORL1 receptors, not NMDA receptors, were suggested as a potential target for treating this condition.", "population_specificity": "Not specified (animal or human study not clearly stated in abstract).", "effective_dosage": "Not specified for D-Aspartic Acid (study focused on MK801).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:55.187590+00:00"}
{"study_id": 11940, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not examine D-Aspartic Acid; it investigates the effects of continuous subcutaneous ketamine infusion on pain in post-herpetic neuralgia patients.", "results_summary": "The study found that ketamine reduced continuous, spontaneous, and evoked pain in post-herpetic neuralgia patients but was associated with intolerable side effects.", "population_specificity": "Patients with post-herpetic neuralgia who reported pain relief after acute intravenous ketamine injection.", "effective_dosage": "0.05, 0.075, 0.10, or 0.15 mg/kg/h via continuous subcutaneous infusion.", "study_duration": "7 days per infusion rate, with one patient discontinuing after 2 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:56.573226+00:00"}
{"study_id": 11941, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of NMDA receptor antagonism (via dizocilpine) on apomorphine-induced aggressive behavior in rats, not specifically D-Aspartic Acid.", "results_summary": "The study found that dizocilpine blocked apomorphine-induced aggression at certain doses but accelerated it at lower doses. Co-administration of apomorphine and dizocilpine prevented aggression development, while CCK antagonists had no effect.", "population_specificity": "Rats sensitized by apomorphine treatment.", "effective_dosage": "Dizocilpine (0.025\u20130.5 mg/kg i.p.), apomorphine (0.5 mg/kg s.c.).", "study_duration": "10 days (apomorphine sensitization), 7 days (dizocilpine treatment in sensitized rats).", "interactions": "None mentioned for D-Aspartic Acid.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:59.065239+00:00"}
{"study_id": 11943, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to analyze the receptive mechanisms for signals mediated by NMDA-sensitive excitatory amino acid receptors and investigate the binding interactions of various compounds, including D-aspartic acid, with these receptors.", "results_summary": "The study found that NMDA-sensitive receptors involve multiple domains (NMDA, glycine, polyamine, and ionophore) and identified potential endogenous agonists. D-aspartic acid's role was implied in receptor modulation, but direct effects were not explicitly detailed.", "population_specificity": "Synaptic membranes from brain tissue (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:36:59.300678+00:00"}
{"study_id": 11942, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to study the excitotoxic effects of N-methyl-D-aspartic acid (NMDA) and kainic acid (KA) on neuronal injury in organotypic hippocampal slices across different developmental stages.", "results_summary": "The study found that sensitivity to KA toxicity increased with in vitro development, while NMDA toxicity remained consistent across ages. Neuronal damage was reversible in younger cultures (EPD 10-12) but led to neuronal death in mature cultures (EPD 23-26) and with NMDA treatment in all ages.", "population_specificity": "Organotypic hippocampal slices aged to equivalent Postnatal Day (EPD) 10-12, 15-17, and 23-26.", "effective_dosage": "50 microM KA or 50 microM NMDA.", "study_duration": "Analyzed at 0, 3, 6, 9, 12, 24, 48 h, or 5 days post-exposure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:00.625703+00:00"}
{"study_id": 11944, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the antitumoral activity of D-aspartic beta-hydroxamate (DAH) against Friend virus-induced erythroleukemia in mice, focusing on its effects on spleen size, nucleated cell count, hematocrit, and CFU-E proliferation.", "results_summary": "DAH significantly increased survival time in treated mice, inhibited virus-induced splenomegaly and polycythemia, and reduced CFU-E proliferation in infected mice. In vitro, DAH inhibited colony formation by infected CFU-E at doses starting at 3 mM.", "population_specificity": "DBA/2 mice infected with Friend virus (FV-P).", "effective_dosage": "2 g/kg/day, administered as a single daily intraperitoneal injection.", "study_duration": "95 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:02.281887+00:00"}
{"study_id": 11945, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-tumoral activity of D-aspartic acid beta-hydroxamate (DAH) against murine leukemia and Friend virus-induced erythroleukemia in vitro and in vivo.", "results_summary": "DAH inhibited cell growth in vitro (2 mM concentration) and significantly increased survival time (212%) in treated mice. It also reduced spleen CFU-E counts, inhibited splenomegaly, prevented polycythemia, and reduced viremia in infected mice.", "population_specificity": "DBA/2 mice infected with Friend virus (FV-P).", "effective_dosage": "Single daily intraperitoneal injection (specific dosage not stated).", "study_duration": "95 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:02.763925+00:00"}
{"study_id": 11946, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to examine the behavioral effects of MK-801, an NMDA receptor antagonist, in neonatal-6-OHDA lesioned rats compared to controls, and its interaction with dopamine systems.", "results_summary": "MK-801 increased behavioral activation in neonatal-6-OHDA lesioned rats, with greater sensitivity in females. The effect was partially mediated by catecholamines and required combined D1/D2 dopamine antagonists to reduce activity. MK-801 also modulated c-fos-like immunoreactivity in specific brain regions, distinct from dopamine agonists.", "population_specificity": "Neonatal-6-OHDA lesioned rats and unlesioned controls.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:03.742667+00:00"}
{"study_id": 11948, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were investigating the mechanism of action of amantadine on NMDA receptor-mediated acetylcholine release in rat neostriatum, not D-Aspartic Acid.", "results_summary": "The study found that amantadine non-competitively inhibits NMDA receptor-mediated acetylcholine release in rat neostriatum at low micromolar concentrations but does not affect dopamine release in the same range.", "population_specificity": "Rat neostriatal tissue (in vitro)", "effective_dosage": "Low micromolar range (exact amount not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:04.900863+00:00"}
{"study_id": 11947, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of NMDA receptor stimulation and antagonism on extracellular dopamine, GABA, and glutamate levels in the dorsolateral striatum of rats.", "results_summary": "NMDA perfusion increased dopamine and GABA outflow, with higher doses also slightly increasing glutamate levels. These effects were counteracted by MK-801, and responses varied under TTX and low Ca2+ conditions, indicating differential regulation of neurotransmitter systems by NMDA receptors.", "population_specificity": "Halothane-anesthetized rats", "effective_dosage": "NMDA (10^(-3) M and 10^(-4) M), MK-801 (10^(-6) M and 10^(-5) M), TTX (10^(-5) M), low Ca2+ (0.1 mM)", "study_duration": "10-minute local perfusion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:06.290087+00:00"}
{"study_id": 11950, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether NMDA receptor antagonists, including D-CPP (a competitive NMDA antagonist), could reduce central sensitization and windup in spinal cord neurons induced by primary afferent stimulation.", "results_summary": "The study found that both non-competitive (MK-801) and competitive (D-CPP) NMDA antagonists reduced facilitation of the flexor reflex and prevented windup in motoneurones, indicating NMDA receptor involvement in central sensitization. These effects were observed after brief electrical stimulation or chemical irritation.", "population_specificity": "Animal model (flexor motoneurones in spinal cord)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:08.650882+00:00"}
{"study_id": 11949, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if amantadine exerts its anti-Parkinsonian effects via NMDA receptor blockade and if it could protect against neurodegenerative processes caused by brain ischemia.", "results_summary": "The study found that amantadine inhibits NMDA receptor-mediated acetylcholine release in rat neostriatum at low micromolar concentrations, suggesting its anti-Parkinsonian effect may involve NMDA receptor blockade. Additionally, amantadine was shown to inhibit NMDA-induced cell death in neuronal cultures, indicating potential neuroprotective effects against ischemia.", "population_specificity": "Rat neostriatum and neuronal cultures", "effective_dosage": "Low micromolar concentrations (exact dosage not specified)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:09.430555+00:00"}
{"study_id": 11952, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the potency, selectivity, and therapeutic potential of a series of NMDA receptor antagonists, including D-Aspartic Acid derivatives, for treating neurological disorders.", "results_summary": "The study found that compound 15 (LY233053) was a potent and selective NMDA receptor antagonist, effectively blocking NMDA-induced convulsions in neonatal rats and lethality in mice. The compounds demonstrated a shorter duration of action, which may be beneficial for acute conditions like stroke.", "population_specificity": "Neonatal rats and mice", "effective_dosage": "20 mg/kg ip (rats), 5 mg/kg ip (mice)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:11.446327+00:00"}
{"study_id": 11954, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of NMDA receptors in c-fos protein-like immunoreactivity in the arcuate nucleus-median eminence of immature female rats.", "results_summary": "NMDA-induced c-fos protein-like immunoreactivity was observed in the arcuate nucleus-median eminence region, which was blocked by NMDA receptor antagonists (MK-801, APV) and attenuated by prior MSG treatment. These findings suggest NMDA receptors are involved in c-fos expression in this region.", "population_specificity": "Immature female rats", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:12.543639+00:00"}
{"study_id": 11951, "supplement_id": 1064, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticonvulsant effects and behavioral impact of NMDA receptor antagonists, including CGP 37849 and CGP 39551, compared to MK-801 and carbamazepine in amygdala-kindled rats.", "results_summary": "The NMDA receptor antagonists (CGP 37849, CGP 39551, and MK-801) showed weak anticonvulsant effects in fully kindled rats and did not increase seizure threshold, while also causing significant behavioral side effects like ataxia and hyperactivity. The study suggests these compounds are unlikely to be clinically useful for treating partial or generalized seizures.", "population_specificity": "Amygdala-kindled rats (a model for complex partial and secondarily generalized seizures).", "effective_dosage": "1 to 10 mg/kg (CGP 37849 or CGP 39551), 0.05 to 0.3 mg/kg (MK-801), and 20 to 40 mg/kg (carbamazepine), administered intraperitoneally.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:12.794803+00:00"}
{"study_id": 11955, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether glutamate, acting via NMDA receptors, serves as an excitatory factor in the neural regulation of sexual maturation in rats.", "results_summary": "NMDA antagonists delayed vaginal opening (VO) but did not prevent it, while NMDA alone synchronized VO timing. MK-801 (1 mg/kg) arrested ovulation at proestrus, but this was reversible upon discontinuation.", "population_specificity": "Immature female rats", "effective_dosage": "Dextrorphan (18 mg/kg), MK-801 (0.1 mg/kg and 1 mg/kg), NMDA (15 mg/kg)", "study_duration": "Daily injections beginning on postnatal day 27 until VO or ovulation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:13.920701+00:00"}
{"study_id": 11953, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the NMDA receptor antagonist activity of LY233053, a tetrazole-containing competitive N-methyl-D-aspartic acid (NMDA) antagonist, and its potential therapeutic effects in conditions involving neuronal cell loss due to NMDA receptor excitotoxicity.", "results_summary": "LY233053 potently inhibited NMDA receptor binding and selectively blocked NMDA-induced effects in various animal models, demonstrating neuroprotective potential with a relatively short duration of action. It was effective in preventing NMDA-induced convulsions, behavioral suppression, and neuronal degeneration, suggesting therapeutic value in acute conditions like cerebral ischemia.", "population_specificity": "Neonatal rats, pigeons, and mice.", "effective_dosage": "14.5 mg/kg i.p. (rats), 1.3 mg/kg i.m. (pigeons), 19.9 mg/kg i.p. (mice), 160 mg/kg i.m. (pigeons for catalepsy).", "study_duration": "Short-term (2-4 hours for some effects).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:14.607089+00:00"}
{"study_id": 186429, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of D-aspartic acid (DAA) supplementation on hormonal and hematological responses in athletes during a simulated altitude protocol.", "results_summary": "The study hypothesized that DAA would increase luteinizing hormone (LH), free testosterone, and hematological variables, but the abstract does not provide specific results regarding these outcomes.", "population_specificity": "Sixteen male boxers.", "effective_dosage": "6 g/day of DAA.", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:16.145138+00:00"}
{"study_id": 11956, "supplement_id": 1064, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether neuroexcitatory amino acids, specifically via NMDA receptor activation, play a role in generating intermittent hypothalamic GnRH release and pulsatile LH secretion in male rats.", "results_summary": "The study found that the NMDA receptor antagonist AP5 significantly suppressed pulsatile LH secretion, suggesting that neuroexcitatory amino acids acting at the NMDA receptor may physiologically regulate GnRH release. Norvaline, a structurally related amino acid, had no such effect.", "population_specificity": "Male rats, including intact and acutely castrated individuals.", "effective_dosage": "AP5 (3.75 mg/injection/rat, ~13.6 mg/kg BW/injection) administered intravenously at 15-minute intervals for four doses.", "study_duration": "Blood samples were collected for 1 hour before and 2 hours after AP5 treatment initiation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:16.901734+00:00"}
{"study_id": 186432, "supplement_id": 1064, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-aspartic acid supplementation increases endogenous testosterone levels or improves muscular performance in resistance-trained men.", "results_summary": "The study found no significant changes in testosterone levels or muscle strength with D-aspartic acid supplementation compared to placebo, though body composition and strength improved equally in both groups due to resistance training. Serum D-aspartate oxidase levels increased slightly in the D-ASP group.", "population_specificity": "Resistance-trained men", "effective_dosage": "3 g/day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:17.373049+00:00"}
{"study_id": 12238, "supplement_id": 1065, "safety_score": "30", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether glabridin could mitigate oxidative damage and cellular dysfunction caused by 2-deoxy-D-ribose (dRib) in osteoblastic cells.", "results_summary": "dRib reduced cell survival and mitochondrial function while increasing ROS and apoptosis, but glabridin pretreatment attenuated these effects and enhanced osteoblast differentiation markers and antioxidant enzyme expression.", "population_specificity": "MC3T3-E1 mouse osteoblastic cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:20.553722+00:00"}
{"study_id": 12237, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-ribose could protect against cisplatin-induced nephrotoxicity by inhibiting inflammatory reactions.", "results_summary": "D-ribose attenuated cisplatin-induced increases in inflammatory markers (TNF-\u03b1, MCP-1, ICAM-1 mRNA) and reduced renal dysfunction and tubular necrosis. The study suggests D-ribose may be a therapeutic candidate for cisplatin-induced nephrotoxicity.", "population_specificity": "48 mice divided into four experimental groups.", "effective_dosage": "400 mg/kg body weight, administered intraperitoneally immediately after cisplatin injection.", "study_duration": "72 hours after cisplatin injection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:20.798781+00:00"}
{"study_id": 12239, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the inhibitory effects of Cf2891, a D-Ribose derivative, on pyrimidine and purine nucleoside phosphorylases (NPs) and its potential role in nucleoside-based combination therapy.", "results_summary": "Cf2891 inhibited various NPs, particularly uridine- and inosine-hydrolyzing enzymes, by competing with inorganic phosphate for binding. It also prevented the breakdown of pyrimidine analogues used in viral and cancer treatments, suggesting potential as a lead molecule for combination therapy.", "population_specificity": "Not specified (in vitro or enzymatic study, no human or animal subjects mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:21.275199+00:00"}
{"study_id": 12240, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the protective effects of gliclazide and NAC against oxidative damage induced by 2-deoxy-D-ribose (dRib) in HIT-T15 cells.", "results_summary": "dRib induced oxidative damage, cell death, and apoptosis in HIT-T15 cells. NAC treatment markedly reduced these effects, while gliclazide had a weaker protective effect, primarily due to its inability to restore intracellular glutathione levels.", "population_specificity": "HIT-T15 cells (a pancreatic \u03b2-cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:22.225976+00:00"}
{"study_id": 12241, "supplement_id": 1065, "safety_score": "30", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine whether D-ribose participates in glycation and leads to the production of advanced glycation end products (AGEs) in vivo, comparing its effects to D-glucose.", "results_summary": "D-ribose treatment decreased cell viability, induced AGE accumulation in cells and mouse brains, and impaired spatial learning and memory in mice, while D-glucose did not show similar effects.", "population_specificity": "Cultured cells and C57BL/6J mice.", "effective_dosage": "High doses (specific amounts not provided).", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:22.838682+00:00"}
{"study_id": 12242, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to synthesize enantiopure cocaine analogues from D-(-)-ribose for potential use in treating cocaine addiction and immunotherapy.", "results_summary": "The study successfully synthesized C6,7 and C7 enantiopure cocaine analogues using a trans-acetonide controlled endo-selective intramolecular nitrone-alkene cycloaddition (INAC) as the key step, enabling practical preparation for bioevaluation.", "population_specificity": "Not specified (in vitro or chemical synthesis study).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:25.317038+00:00"}
{"study_id": 12244, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether kaempferol could mitigate dRib-induced osteoblast dysfunction and oxidative damage in MC3T3-E1 cells.", "results_summary": "Kaempferol significantly counteracted dRib-induced cell growth reduction, enhanced osteoblast function markers (ALP activity, collagen content, mineralization), increased OPG secretion, and reduced lipid peroxidation (MDA levels).", "population_specificity": "MC3T3-E1 mouse osteoblastic cell line", "effective_dosage": "30 mM dRib; kaempferol (10^(-9)-10^(-5) M)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:25.771854+00:00"}
{"study_id": 12243, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify new drug targets for tuberculosis treatment, focusing on the role of D-Ribose in the biosynthesis of D-arabinose, a critical component of the mycobacterial cell wall.", "results_summary": "The study found that targeting the heteromeric decaprenylphosphoryl-\u03b2-D-ribose 2'-epimerase (involved in D-Ribose transformation) is highly effective against M. tuberculosis, including drug-resistant strains, making it a promising drug target.", "population_specificity": "Mycobacterium tuberculosis strains, including multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:26.861017+00:00"}
{"study_id": 12246, "supplement_id": 1065, "safety_score": "80", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to re-examine the clinical efficacy of D-ribose in improving neurological outcomes and reducing seizure frequency in patients with ADSL deficiency.", "results_summary": "The 12-month trial of D-ribose showed no clinical benefit in ADSL patients, with no reduction in seizure frequency or growth enhancement. Two patients with milder phenotypes even experienced their first seizures during treatment.", "population_specificity": "Four ADSL-deficient patients, including both milder and severe phenotypes.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:28.903368+00:00"}
{"study_id": 12245, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of D-dRib in tumor progression and explore its inhibition as a potential chemotherapy approach for various tumors.", "results_summary": "The study found that D-dRib promotes angiogenesis, chemotactic activity of endothelial cells, and resistance to hypoxia-induced apoptosis in cancer cell lines, suggesting it as a downstream mediator of TP function. Its stereoisomer, 2-Deoxy-L-ribose, can inhibit these effects and suppress metastasis in TP-expressing tumors.", "population_specificity": "Cancer cell lines and TP-expressing tumors in mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:29.108208+00:00"}
{"study_id": 12249, "supplement_id": 1065, "safety_score": "90", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the embryotoxicity and teratogenicity of D-Ribose in pregnant rats.", "results_summary": "The study found no significant adverse effects on fetal development or maternal health at doses up to 20% DR in the diet, with a NOAEL for teratogenicity at 5% DR.", "population_specificity": "Pregnant female rats", "effective_dosage": "0, 5, 10, or 20% DR (0.0, 4.25, 7.94, 9.91g/kg body weight/day)", "study_duration": "From day 0 of gestation until day 21 (Caesarian section)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:31.314886+00:00"}
{"study_id": 12247, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to elucidate the mechanisms by which 2-deoxy-D-ribose (dRib) induces oxidative stress and apoptosis by depleting glutathione (GSH).", "results_summary": "The study found that dRib depletes GSH by inhibiting its synthesis (via gamma-glutamyl-cysteine synthetase inhibition) and increasing its efflux (via multidrug resistance-associated protein transporters). This GSH depletion leads to oxidative stress and apoptosis, but dRib does not directly oxidize GSH.", "population_specificity": "Not specified (likely in vitro or animal model based on the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:31.890049+00:00"}
{"study_id": 12248, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effect of pyridoxal-5'-phosphate (PLP) on 2-deoxy-D-ribose (dRib)-induced oxidative damage and apoptosis in human monocytic cells (U937).", "results_summary": "dRib induced oxidative stress and apoptosis in U937 cells, but PLP treatment significantly reduced ROS production, glutathione depletion, lipid peroxidation, protein oxidation, and apoptotic markers. The antioxidant NAC also mitigated apoptosis, suggesting PLP's protective role is mediated through antioxidant mechanisms.", "population_specificity": "Human monocytic cells (U937) in vitro.", "effective_dosage": "dRib (30 mM); PLP (100 and 250 microM).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:32.834750+00:00"}
{"study_id": 12252, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to determine whether D-Ribose supplementation improves ATP recovery, ischemic threshold, and diastolic function in congestive heart failure patients.", "results_summary": "The study found that ribose supplementation aids ATP recovery, improves ischemic threshold, and enhances diastolic function in congestive heart failure patients. Clinical trials supported these benefits.", "population_specificity": "Patients with congestive heart failure", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:33.915277+00:00"}
{"study_id": 12251, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of low-energy Ar+ ion irradiation on the decomposition and fragmentation of D-ribose and 2-deoxy-D-ribose in a condensed phase.", "results_summary": "The study found that Ar+ ion irradiation at energies as low as 15 eV effectively decomposes D-ribose and 2-deoxy-D-ribose, producing various cation and anion fragments. The fragmentation involves breaking of chemical bonds, including endo- and exocyclic C-O bonds, and leads to hydrogen abstraction and proton transfer reactions.", "population_specificity": "Polycrystalline Pt substrate (in vitro study, no human or animal subjects).", "effective_dosage": "Not applicable (ion irradiation study).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:35.411050+00:00"}
{"study_id": 12250, "supplement_id": 1065, "safety_score": "85", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the toxicity of sub-chronic D-ribose administration in male and female Wistar rats to determine the no observed adverse effect level (NOAEL).", "results_summary": "The study found decreased mean body weights in treated animals and increased cecal weights, but no microscopic histopathology changes attributable to D-ribose. The NOAEL was determined to be 5% DR in the diet (3.6-4.4 g/kg/day).", "population_specificity": "Male and female albino Wistar rats.", "effective_dosage": "0%, 5%, 10%, or 20% DR in diet (0.0, 3.6, 7.6, 15.0 g/kg/day for males; 0.0, 4.4, 8.5, 15.7 g/kg/day for females).", "study_duration": "13 consecutive weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:35.886744+00:00"}
{"study_id": 12253, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to characterize the intracellular events underlying the apoptotic effects of 2-deoxy-d-ribose (dRib) and the role of polyamines in these effects.", "results_summary": "Treatment with dRib induced mitochondrial dysfunction, oxidative stress, and cell death, with the mode of death (apoptosis or necrosis) depending on intracellular polyamine levels. Polyamine-depleted cells underwent necrosis, while cells with normal polyamine levels underwent apoptosis.", "population_specificity": "HL-60 cells (a human leukemia cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:37.597397+00:00"}
{"study_id": 12254, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether rapamycin could counteract the pro-angiogenic effects of 2-deoxy-D-ribose (dRib) induced by 5-FU therapy in colorectal cancer.", "results_summary": "Rapamycin effectively inhibited dRib-induced angiogenesis and tumor growth, both in orthotopic and metastatic models, and blocked dRib-induced p70/S6 kinase activation in endothelial cells. Combination therapy with rapamycin and 5-FU prevented tumor development and metastatic expansion.", "population_specificity": "BALB/c mice with TP-expressing CT-26 colon adenocarcinoma cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:38.455607+00:00"}
{"study_id": 12255, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of oral D-ribose supplementation on cardiac hemodynamics and quality of life in patients with chronic coronary artery disease and congestive heart failure.", "results_summary": "D-ribose improved diastolic functional parameters (e.g., atrial contribution to left ventricular filling, left atrial dimension, E wave deceleration) and significantly enhanced quality of life compared to placebo.", "population_specificity": "15 patients with chronic coronary artery disease and congestive heart failure.", "effective_dosage": "Not specified", "study_duration": "Two 3-week treatment periods with a 1-week washout in between.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:39.542351+00:00"}
{"study_id": 12256, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to synthesize 5-thio-D-ribopyranose from D-ribono-1,4-lactone using two different chemical approaches.", "results_summary": "The study successfully synthesized 5-thio-D-ribopyranose via two methods, achieving overall yields of 46-48% and 57%, respectively. The abstract does not report on biological effects or clinical outcomes of D-Ribose.", "population_specificity": "Not applicable (chemical synthesis study)", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:39.746506+00:00"}
{"study_id": 12257, "supplement_id": 1065, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the molecular mechanism by which 2-deoxy-D-ribose confers resistance to hypoxia-induced apoptosis and its potential role in anti-tumor therapy.", "results_summary": "2-deoxy-D-ribose partially prevented hypoxia-induced apoptosis by inhibiting caspase-mediated pathways, including caspase 3 activation, mitochondrial cytochrome c release, and modulation of Bcl-2 and Bcl-x(L). Its analogs may enhance apoptosis and suppress tumor growth by competitively inhibiting 2-deoxy-D-ribose activities.", "population_specificity": "Human leukemia HL-60 cell line", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:37:41.565354+00:00"}
